ghc-20220630
false2022Q2000010488912/311P10Y00001048892022-01-012022-06-300000104889us-gaap:CommonClassAMember2022-07-29xbrli:shares0000104889us-gaap:CommonClassBMember2022-07-290000104889us-gaap:ServiceMember2022-04-012022-06-30iso4217:USD0000104889us-gaap:ServiceMember2021-04-012021-06-300000104889us-gaap:ServiceMember2022-01-012022-06-300000104889us-gaap:ServiceMember2021-01-012021-06-300000104889us-gaap:ProductMember2022-04-012022-06-300000104889us-gaap:ProductMember2021-04-012021-06-300000104889us-gaap:ProductMember2022-01-012022-06-300000104889us-gaap:ProductMember2021-01-012021-06-3000001048892022-04-012022-06-3000001048892021-04-012021-06-3000001048892021-01-012021-06-30iso4217:USDxbrli:shares00001048892022-06-3000001048892021-12-3100001048892020-12-3100001048892021-06-300000104889us-gaap:CommonStockMember2021-12-310000104889us-gaap:AdditionalPaidInCapitalMember2021-12-310000104889us-gaap:RetainedEarningsMember2021-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000104889us-gaap:TreasuryStockMember2021-12-310000104889us-gaap:NoncontrollingInterestMember2021-12-310000104889us-gaap:RetainedEarningsMember2022-01-012022-03-3100001048892022-01-012022-03-310000104889us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000104889us-gaap:TreasuryStockMember2022-01-012022-03-310000104889us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000104889us-gaap:CommonStockMember2022-03-310000104889us-gaap:AdditionalPaidInCapitalMember2022-03-310000104889us-gaap:RetainedEarningsMember2022-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000104889us-gaap:TreasuryStockMember2022-03-310000104889us-gaap:NoncontrollingInterestMember2022-03-3100001048892022-03-310000104889us-gaap:RetainedEarningsMember2022-04-012022-06-300000104889us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000104889us-gaap:TreasuryStockMember2022-04-012022-06-300000104889us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000104889us-gaap:CommonStockMember2022-06-300000104889us-gaap:AdditionalPaidInCapitalMember2022-06-300000104889us-gaap:RetainedEarningsMember2022-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000104889us-gaap:TreasuryStockMember2022-06-300000104889us-gaap:NoncontrollingInterestMember2022-06-300000104889us-gaap:CommonStockMember2020-12-310000104889us-gaap:AdditionalPaidInCapitalMember2020-12-310000104889us-gaap:RetainedEarningsMember2020-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000104889us-gaap:TreasuryStockMember2020-12-310000104889us-gaap:NoncontrollingInterestMember2020-12-310000104889us-gaap:RetainedEarningsMember2021-01-012021-03-3100001048892021-01-012021-03-310000104889us-gaap:NoncontrollingInterestMember2021-01-012021-03-310000104889us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000104889us-gaap:TreasuryStockMember2021-01-012021-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000104889us-gaap:CommonStockMember2021-03-310000104889us-gaap:AdditionalPaidInCapitalMember2021-03-310000104889us-gaap:RetainedEarningsMember2021-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000104889us-gaap:TreasuryStockMember2021-03-310000104889us-gaap:NoncontrollingInterestMember2021-03-3100001048892021-03-310000104889us-gaap:RetainedEarningsMember2021-04-012021-06-300000104889us-gaap:NoncontrollingInterestMember2021-04-012021-06-300000104889us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300000104889us-gaap:TreasuryStockMember2021-04-012021-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000104889us-gaap:CommonStockMember2021-06-300000104889us-gaap:AdditionalPaidInCapitalMember2021-06-300000104889us-gaap:RetainedEarningsMember2021-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000104889us-gaap:TreasuryStockMember2021-06-300000104889us-gaap:NoncontrollingInterestMember2021-06-300000104889ghc:TelevisionBroadcastingMember2022-06-30ghc:televisionStation0000104889ghc:AutodealershipsMemberus-gaap:SubsequentEventMemberghc:AutomotiveMember2022-07-05ghc:store0000104889ghc:GrahamHealthcareGroupMember2022-05-012022-05-31ghc:business00001048892021-01-012021-12-310000104889ghc:EducationMember2021-01-012021-12-310000104889ghc:GrahamHealthcareGroupMember2021-01-012021-12-310000104889ghc:AutomotiveMember2021-01-012021-12-310000104889us-gaap:AllOtherSegmentsMember2021-01-012021-12-310000104889ghc:LeafGroupMemberus-gaap:AllOtherSegmentsMember2021-06-142021-06-140000104889ghc:LeafGroupMemberus-gaap:AllOtherSegmentsMember2021-06-140000104889ghc:GrahamHealthcareGroupMember2021-12-012021-12-310000104889ghc:WeissMemberghc:GrahamHealthcareGroupMember2021-12-31xbrli:pure0000104889ghc:WeissMembersrt:MaximumMemberghc:GrahamHealthcareGroupMember2021-12-310000104889ghc:FordAutoDealershipMemberghc:AutomotiveMember2021-12-280000104889us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2021-12-310000104889ghc:HooverTreatedWoodProductsMemberghc:ManufacturingMember2021-03-012021-03-310000104889ghc:HooverTreatedWoodProductsMemberghc:ManufacturingMember2022-06-300000104889ghc:EducationMember2021-11-012021-11-300000104889ghc:MarkelCorporationMember2022-06-300000104889ghc:MarkelCorporationMember2021-12-310000104889ghc:ConcentrationInSingleMarketableEquitySecurityMember2022-06-30ghc:investment0000104889ghc:ConcentrationInSingleMarketableEquitySecurityMemberus-gaap:AssetsTotalMemberus-gaap:EquitySecuritiesMember2022-01-012022-06-300000104889ghc:IntersectionMember2022-06-300000104889ghc:ResidentialHomeHealthIllinoisMemberghc:GrahamHealthcareGroupMember2022-06-300000104889ghc:ResidentialHospiceIllinoisMemberghc:GrahamHealthcareGroupMember2022-06-300000104889ghc:ResidentialAndMichiganHospitalJointVentureMemberghc:GrahamHealthcareGroupMember2022-06-300000104889ghc:CelticHealthcareAlleghenyHealthNetworkJointVentureMemberghc:GrahamHealthcareGroupMember2022-06-300000104889ghc:ResidentialHomeHealthIllinoisAndResidentialHospiceIllinoisMemberghc:GrahamHealthcareGroupMember2022-01-012022-03-310000104889ghc:ResidentialHospiceIllinoisMemberghc:GrahamHealthcareGroupMember2022-01-012022-03-310000104889ghc:GrahamHealthcareGroupMember2022-04-012022-06-300000104889ghc:GrahamHealthcareGroupMember2022-01-012022-06-300000104889ghc:GrahamHealthcareGroupMember2021-04-012021-06-300000104889ghc:GrahamHealthcareGroupMember2021-01-012021-06-300000104889ghc:KIHLMemberghc:YorkJointVentureMember2022-06-30iso4217:GBP0000104889ghc:KIHLMemberghc:YorkJointVentureMember2022-01-012022-06-300000104889ghc:TruistFloorPlanFacilityMemberghc:SecuredOvernightFinancingRatesSOFRMemberghc:AutomotiveMember2022-01-012022-06-300000104889ghc:FordFloorPlanFacilityMemberus-gaap:PrimeRateMembersrt:MinimumMemberghc:AutomotiveMember2022-06-300000104889ghc:FordFloorPlanFacilityMemberus-gaap:PrimeRateMemberghc:AutomotiveMember2022-01-012022-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2022-04-012022-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2021-04-012021-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2022-01-012022-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2021-01-012021-06-300000104889ghc:AutomotiveMember2022-06-300000104889ghc:AutomotiveMember2022-04-012022-06-300000104889ghc:AutomotiveMember2021-04-012021-06-300000104889ghc:AutomotiveMember2022-01-012022-06-300000104889ghc:AutomotiveMember2021-01-012021-06-300000104889ghc:EducationMember2021-12-310000104889ghc:TelevisionBroadcastingMember2021-12-310000104889ghc:ManufacturingMember2021-12-310000104889ghc:GrahamHealthcareGroupMember2021-12-310000104889ghc:AutomotiveMember2021-12-310000104889us-gaap:AllOtherSegmentsMember2021-12-310000104889ghc:EducationMember2022-01-012022-06-300000104889ghc:TelevisionBroadcastingMember2022-01-012022-06-300000104889ghc:ManufacturingMember2022-01-012022-06-300000104889ghc:GrahamHealthcareGroupMember2022-01-012022-06-300000104889us-gaap:AllOtherSegmentsMember2022-01-012022-06-300000104889ghc:EducationMember2022-06-300000104889ghc:ManufacturingMember2022-06-300000104889ghc:GrahamHealthcareGroupMember2022-06-300000104889us-gaap:AllOtherSegmentsMember2022-06-300000104889ghc:EducationMemberghc:KaplanInternationalMember2021-12-310000104889ghc:EducationMemberghc:HigherEducationMember2021-12-310000104889ghc:EducationMemberghc:SupplementalEducationMember2021-12-310000104889ghc:EducationMemberghc:KaplanInternationalMember2022-01-012022-06-300000104889ghc:EducationMemberghc:HigherEducationMember2022-01-012022-06-300000104889ghc:EducationMemberghc:SupplementalEducationMember2022-01-012022-06-300000104889ghc:EducationMemberghc:KaplanInternationalMember2022-06-300000104889ghc:EducationMemberghc:HigherEducationMember2022-06-300000104889ghc:EducationMemberghc:SupplementalEducationMember2022-06-300000104889us-gaap:CustomerRelationshipsMembersrt:MinimumMember2021-01-012021-12-310000104889us-gaap:CustomerRelationshipsMembersrt:MinimumMember2022-01-012022-06-300000104889us-gaap:CustomerRelationshipsMembersrt:MaximumMember2021-01-012021-12-310000104889us-gaap:CustomerRelationshipsMembersrt:MaximumMember2022-01-012022-06-300000104889us-gaap:CustomerRelationshipsMember2022-06-300000104889us-gaap:CustomerRelationshipsMember2021-12-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2022-01-012022-06-300000104889us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2021-01-012021-12-310000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2021-01-012021-12-310000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2022-01-012022-06-300000104889us-gaap:TrademarksAndTradeNamesMember2022-06-300000104889us-gaap:TrademarksAndTradeNamesMember2021-12-310000104889us-gaap:DatabasesMembersrt:MinimumMember2022-01-012022-06-300000104889us-gaap:DatabasesMembersrt:MinimumMember2021-01-012021-12-310000104889srt:MaximumMemberus-gaap:DatabasesMember2021-01-012021-12-310000104889srt:MaximumMemberus-gaap:DatabasesMember2022-01-012022-06-300000104889us-gaap:DatabasesMember2022-06-300000104889us-gaap:DatabasesMember2021-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2021-01-012021-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2022-01-012022-06-300000104889us-gaap:ContractBasedIntangibleAssetsMember2022-06-300000104889us-gaap:ContractBasedIntangibleAssetsMember2021-12-310000104889us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2022-01-012022-06-300000104889us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2021-01-012021-12-310000104889us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2022-01-012022-06-300000104889us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2021-01-012021-12-310000104889us-gaap:NoncompeteAgreementsMember2022-06-300000104889us-gaap:NoncompeteAgreementsMember2021-12-310000104889us-gaap:OtherIntangibleAssetsMembersrt:MinimumMember2022-01-012022-06-300000104889us-gaap:OtherIntangibleAssetsMembersrt:MinimumMember2021-01-012021-12-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2021-01-012021-12-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2022-01-012022-06-300000104889us-gaap:OtherIntangibleAssetsMember2022-06-300000104889us-gaap:OtherIntangibleAssetsMember2021-12-310000104889us-gaap:TrademarksAndTradeNamesMember2022-06-300000104889us-gaap:TrademarksAndTradeNamesMember2021-12-310000104889us-gaap:FranchiseRightsMember2022-06-300000104889us-gaap:FranchiseRightsMember2021-12-310000104889us-gaap:OperatingAndBroadcastRightsMember2022-06-300000104889us-gaap:OperatingAndBroadcastRightsMember2021-12-310000104889ghc:LicensureAndAccreditationMember2022-06-300000104889ghc:LicensureAndAccreditationMember2021-12-310000104889us-gaap:OtherIntangibleAssetsMember2022-06-300000104889us-gaap:OtherIntangibleAssetsMember2021-12-310000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2022-06-300000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2021-12-310000104889ghc:FiveYearCreditAgreementMaturingIn2027Membersrt:MinimumMember2022-06-300000104889srt:MaximumMemberghc:FiveYearCreditAgreementMaturingIn2027Member2022-06-300000104889ghc:FiveYearCreditAgreementMaturingIn2027Member2022-06-300000104889ghc:FiveYearCreditAgreementMaturingIn2027Member2021-12-310000104889ghc:CommercialNoteWithTruistBankDueIn2031Membersrt:MinimumMember2022-06-300000104889srt:MaximumMemberghc:CommercialNoteWithTruistBankDueIn2031Member2022-06-300000104889ghc:CommercialNoteWithTruistBankDueIn2031Member2022-06-300000104889ghc:CommercialNoteWithTruistBankDueIn2031Member2021-12-310000104889ghc:CommercialNoteWithTruistBankDueIn2032Membersrt:MinimumMember2022-06-300000104889srt:MaximumMemberghc:CommercialNoteWithTruistBankDueIn2032Member2022-06-300000104889ghc:CommercialNoteWithTruistBankDueIn2032Member2022-06-300000104889ghc:CommercialNoteWithTruistBankDueIn2032Member2021-12-310000104889ghc:PinnacleBankTermLoanMember2022-06-300000104889ghc:PinnacleBankTermLoanMember2021-12-310000104889ghc:OtherIndebtednessMembersrt:MinimumMember2022-06-300000104889srt:MaximumMemberghc:OtherIndebtednessMember2022-06-300000104889ghc:USDRevolvingCreditFacilityBorrowingsMember2022-06-300000104889ghc:USDRevolvingCreditFacilityBorrowingsMemberghc:SecuredOvernightFinancingRatesSOFRMember2022-06-302022-06-300000104889ghc:GBPRevolvingCreditFacilityBorrowingsMember2022-06-300000104889ghc:GBPRevolvingCreditFacilityBorrowingsMemberghc:SterlingOvernightInterbankAverageRateSONIAMember2022-06-302022-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2022-04-012022-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2022-01-012022-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2021-04-012021-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2021-01-012021-06-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000104889us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000104889us-gaap:FairValueMeasurementsRecurringMember2022-06-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000104889us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000104889us-gaap:FairValueMeasurementsRecurringMember2021-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2021-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2022-01-012022-06-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2022-06-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2020-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2020-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2021-01-012021-06-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2021-06-300000104889country:US2022-01-012022-06-300000104889country:US2022-04-012022-06-300000104889us-gaap:NonUsMember2022-04-012022-06-300000104889us-gaap:NonUsMember2022-01-012022-06-300000104889country:US2021-04-012021-06-300000104889country:US2021-01-012021-06-300000104889us-gaap:NonUsMember2021-04-012021-06-300000104889us-gaap:NonUsMember2021-01-012021-06-300000104889us-gaap:TransferredOverTimeMember2022-01-012022-06-300000104889us-gaap:TransferredOverTimeMember2022-04-012022-06-300000104889us-gaap:TransferredAtPointInTimeMember2022-04-012022-06-300000104889us-gaap:TransferredAtPointInTimeMember2022-01-012022-06-300000104889us-gaap:TransferredOverTimeMember2021-04-012021-06-300000104889us-gaap:TransferredOverTimeMember2021-01-012021-06-300000104889us-gaap:TransferredAtPointInTimeMember2021-04-012021-06-300000104889us-gaap:TransferredAtPointInTimeMember2021-01-012021-06-300000104889ghc:KaplanInternationalMember2022-06-300000104889ghc:KaplanInternationalMemberus-gaap:LongTermContractWithCustomerMember2022-07-012022-06-300000104889ghc:KaplanInternationalMember2021-12-310000104889ghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMemberghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Member2020-04-012020-04-300000104889ghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMemberghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Member2022-04-012022-06-300000104889ghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMemberghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Member2022-01-012022-06-300000104889ghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMemberghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Member2022-06-300000104889ghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMemberghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Member2021-01-012021-06-300000104889ghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMemberghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Member2021-04-012021-06-300000104889us-gaap:LongTermContractWithCustomerMemberghc:SupplementalEducationMember2022-01-012022-06-300000104889us-gaap:LongTermContractWithCustomerMember2022-07-01ghc:SupplementalEducationMember2022-06-300000104889us-gaap:LongTermContractWithCustomerMemberghc:SupplementalEducationMember2022-06-300000104889us-gaap:EmployeeStockOptionMember2022-04-012022-06-300000104889us-gaap:EmployeeStockOptionMember2021-04-012021-06-300000104889us-gaap:EmployeeStockOptionMember2022-01-012022-06-300000104889us-gaap:EmployeeStockOptionMember2021-01-012021-06-300000104889us-gaap:RestrictedStockMember2022-04-012022-06-300000104889us-gaap:RestrictedStockMember2021-04-012021-06-300000104889us-gaap:RestrictedStockMember2022-01-012022-06-300000104889us-gaap:RestrictedStockMember2021-01-012021-06-300000104889us-gaap:EmployeeStockOptionMember2022-04-012022-06-300000104889us-gaap:EmployeeStockOptionMember2021-04-012021-06-300000104889us-gaap:EmployeeStockOptionMember2022-01-012022-06-300000104889us-gaap:EmployeeStockOptionMember2021-01-012021-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2022-04-012022-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2021-04-012021-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:DekkoMemberghc:SeparationIncentiveProgramMember2021-04-012021-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-01-012022-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-04-012022-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2021-04-012021-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2021-01-012021-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:PrivateEquityFundsMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:PrivateEquityFundsMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:EquityFundsUSMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:EquityFundsUSMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:FixedIncomeSecuritiesUSMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:FixedIncomeSecuritiesUSMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2021-12-31ghc:country0000104889us-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager1Memberghc:AlphabetAndBerkshireHathawayCommonStockMember2022-01-012022-06-300000104889us-gaap:PensionPlansDefinedBenefitMembersrt:MaximumMemberghc:InvestmentManager1Memberghc:ForeignInvestmentsMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager2Memberghc:BerkshireHathawayCommonStockMember2022-01-012022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager2Membersrt:MaximumMemberghc:ForeignInvestmentsMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager2Memberus-gaap:FixedIncomeSecuritiesMembersrt:MinimumMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2022-01-012022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:DefinedBenefitPlanAssetsTotalMemberghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMember2022-01-012022-06-300000104889us-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:PrivateEquityFundsMemberghc:SingleEquityConcentrationMember2022-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2022-06-300000104889us-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:PrivateEquityFundsMemberghc:SingleEquityConcentrationMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2021-01-012021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2021-12-310000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-06-300000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-04-012022-06-300000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-04-012021-06-300000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-06-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2022-04-012022-06-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2022-01-012022-06-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2021-04-012021-06-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2021-01-012021-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2022-04-012022-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2021-04-012021-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-04-012022-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-04-012021-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-04-012022-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-04-012021-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-012022-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-012021-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-012022-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-012021-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-01-012022-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-01-012021-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-01-012022-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-012022-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-012021-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-30ghc:claim0000104889srt:MaximumMember2022-06-300000104889ghc:EducationMembersrt:MinimumMember2021-05-012021-05-310000104889ghc:EducationMember2021-07-012021-07-310000104889ghc:EducationMemberghc:KaplanSingaporeMember2021-06-012021-06-30ghc:program0000104889ghc:EducationMemberghc:KaplanSingaporeMember2021-08-232021-08-230000104889ghc:EducationMemberghc:KaplanSingaporeMember2021-11-012021-11-300000104889ghc:EducationMemberghc:KaplanSingaporeMember2022-06-300000104889ghc:EducationMemberghc:DiplomasMemberghc:KaplanSingaporeMember2022-06-300000104889ghc:EducationMemberghc:KaplanSingaporeMemberghc:BachelorsMember2022-06-30ghc:segment0000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2022-04-012022-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2021-04-012021-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2022-01-012022-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2021-01-012021-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2022-04-012022-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2021-04-012021-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2022-01-012022-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2021-01-012021-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2022-04-012022-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2021-04-012021-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2022-01-012022-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2021-01-012021-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-04-012022-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-04-012021-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-01-012022-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-01-012021-06-300000104889us-gaap:CorporateNonSegmentMember2022-04-012022-06-300000104889us-gaap:CorporateNonSegmentMember2021-04-012021-06-300000104889us-gaap:CorporateNonSegmentMember2022-01-012022-06-300000104889us-gaap:CorporateNonSegmentMember2021-01-012021-06-300000104889us-gaap:IntersegmentEliminationMember2022-04-012022-06-300000104889us-gaap:IntersegmentEliminationMember2021-04-012021-06-300000104889us-gaap:IntersegmentEliminationMember2022-01-012022-06-300000104889us-gaap:IntersegmentEliminationMember2021-01-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2021-12-310000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2022-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2021-12-310000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2022-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2021-12-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2022-06-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2021-12-310000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2022-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2021-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-12-310000104889us-gaap:CorporateNonSegmentMember2022-06-300000104889us-gaap:CorporateNonSegmentMember2021-12-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMember2022-04-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMember2021-04-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMember2022-01-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMember2021-01-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberghc:HigherEducationMemberus-gaap:ReportableSubsegmentsMember2022-04-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberghc:HigherEducationMemberus-gaap:ReportableSubsegmentsMember2021-04-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberghc:HigherEducationMemberus-gaap:ReportableSubsegmentsMember2022-01-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberghc:HigherEducationMemberus-gaap:ReportableSubsegmentsMember2021-01-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMember2022-04-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMember2021-04-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMember2022-01-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMember2021-01-012021-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMember2022-04-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMember2021-04-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMember2022-01-012022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMember2021-01-012021-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMember2022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMember2021-12-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberghc:HigherEducationMemberus-gaap:ReportableSubsegmentsMember2022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberghc:HigherEducationMemberus-gaap:ReportableSubsegmentsMember2021-12-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMember2022-06-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMember2021-12-310000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2022-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended June 30, 2022
or
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number 001-06714
GRAHAM HOLDINGS COMPANY
(Exact name of registrant as specified in its charter)
Delaware53-0182885
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1300 North 17th Street, Arlington, Virginia

22209
(Address of principal executive offices)(Zip Code)
(703) 345-6300
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class B Common Stock, par value $1.00 per share GHCNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  .    No  .
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  .    No  .  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated
filer
Non-accelerated
filer
Smaller reporting
company
Emerging growth
company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  .    No  .  
Shares outstanding at July 29, 2022:
Class A Common Stock – 964,001 Shares
Class B Common Stock – 3,878,319 Shares



GRAHAM HOLDINGS COMPANY
Index to Form 10-Q
 
PART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements
 
 
Condensed Consolidated Statements of Operations
 
 
 
 
Condensed Consolidated Statements of Comprehensive (Loss) Income
 
 
 
 
Condensed Consolidated Balance Sheets
 
 
 
 
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Changes in Common Stockholders' Equity
 
 
 
 
Notes to Condensed Consolidated Financial Statements

Organization, Basis of Presentation and Recent Accounting Pronouncements

Acquisitions and Dispositions of Businesses

Investments

Accounts Receivable, Accounts Payable and Accrued Liabilities

Inventories, Contracts in Progress and Vehicle Floor Plan Payable

Goodwill and Other Intangible Assets

Debt

Fair Value Measurements

Revenue From Contracts With Customers

Earnings Per Share

Pension and Postretirement Plans

Other Non-Operating Income

Accumulated Other Comprehensive Income (Loss)

Contingencies

Business Segments
Item 2.
Management’s Discussion and Analysis of Results of Operations and Financial Condition
 
 
 
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
 
 
 
Item 4.
Controls and Procedures
 
 
PART II. OTHER INFORMATION
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 6.
Exhibits
 
 
Signatures



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
  
(in thousands, except per share amounts)2022202120222021
Operating Revenues
Sales of services$563,113 $511,037 $1,120,682 $994,706 
Sales of goods370,189 290,115 727,341 518,901 
933,302 801,152 1,848,023 1,513,607 
Operating Costs and Expenses    
Cost of services sold (exclusive of items shown below)329,702 306,983 654,683 599,417 
Cost of goods sold (exclusive of items shown below)302,126 226,892 592,646 405,679 
Selling, general and administrative227,844 195,429 452,706 371,290 
Depreciation of property, plant and equipment19,413 16,600 38,888 33,145 
Amortization of intangible assets14,889 13,889 29,801 27,826 
Impairment of long-lived assets 3,768  4,815 
  893,974 763,561 1,768,724 1,442,172 
Income from Operations39,328 37,591 79,299 71,435 
Equity in earnings of affiliates, net1,427 1,776 4,031 15,204 
Interest income696 1,876 1,411 2,766 
Interest expense(15,973)(7,353)(27,390)(15,801)
Non-operating pension and postretirement benefit income, net50,871 25,216 101,376 54,003 
(Loss) gain on marketable equity securities, net(165,540)83,698 (118,628)162,912 
Other income, net1,176 16,122 4,052 22,442 
(Loss) Income Before Income Taxes(88,015)158,926 44,151 312,961 
(Benefit from) Provision for Income Taxes(21,400)43,000 14,200 84,400 
Net (Loss) Income(66,615)115,926 29,951 228,561 
Net Income Attributable to Noncontrolling Interests(870)(568)(1,812)(753)
Net (Loss) Income Attributable to Graham Holdings Company Common Stockholders$(67,485)$115,358 $28,139 $227,808 
Per Share Information Attributable to Graham Holdings Company Common Stockholders
      
Basic net (loss) income per common share$(13.95)$23.07 $5.76 $45.55 
Basic average number of common shares outstanding4,842 4,968 4,857 4,968 
Diluted net (loss) income per common share$(13.95)$22.99 $5.74 $45.43 
Diluted average number of common shares outstanding4,842 4,985 4,870 4,981 
See accompanying Notes to Condensed Consolidated Financial Statements.
1


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (UNAUDITED)
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2022202120222021
Net (Loss) Income$(66,615)$115,926 $29,951 $228,561 
Other Comprehensive (Loss) Income, Before Tax      
Foreign currency translation adjustments:      
Translation adjustments arising during the period(40,928)1,167 (42,666)681 
Pension and other postretirement plans:        
Amortization of net prior service cost included in net income
716 792 1,432 1,584 
Amortization of net actuarial gain included in net income
(18,082)(924)(35,856)(3,353)
  (17,366)(132)(34,424)(1,769)
Cash flow hedge gain1,091 13 2,733 634 
Other Comprehensive (Loss) Income, Before Tax(57,203)1,048 (74,357)(454)
Income tax benefit related to items of other comprehensive (loss) income
4,224 32 8,243 331 
Other Comprehensive (Loss) Income, Net of Tax(52,979)1,080 (66,114)(123)
Comprehensive (Loss) Income(119,594)117,006 (36,163)228,438 
Comprehensive income attributable to noncontrolling interests
(870)(568)(1,812)(753)
Total Comprehensive (Loss) Income Attributable to Graham Holdings Company$(120,464)$116,438 $(37,975)$227,685 

See accompanying Notes to Condensed Consolidated Financial Statements.
2


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
As of
(in thousands)June 30,
2022
December 31,
2021
  (Unaudited)  
Assets    
Current Assets    
Cash and cash equivalents$126,368 $145,886 
Restricted cash18,849 12,175 
Investments in marketable equity securities and other investments662,831 824,445 
Accounts receivable, net475,333 607,471 
Inventories and contracts in progress178,280 141,471 
Prepaid expenses97,566 81,741 
Income taxes receivable39,789 32,744 
Other current assets2,411 1,241 
Total Current Assets1,601,427 1,847,174 
Property, Plant and Equipment, Net442,409 468,126 
Lease Right-of-Use Assets434,843 437,969 
Investments in Affiliates172,612 155,444 
Goodwill, Net1,617,648 1,649,582 
Indefinite-Lived Intangible Assets137,545 142,180 
Amortized Intangible Assets, Net216,612 247,120 
Prepaid Pension Cost2,364,135 2,306,514 
Deferred Income Taxes7,042 7,900 
Deferred Charges and Other Assets (includes $646 and $782 of restricted cash)
167,032 163,516 
Total Assets$7,161,305 $7,425,525 
Liabilities and Equity    
Current Liabilities    
Accounts payable and accrued liabilities$560,122 $583,629 
Deferred revenue283,701 358,720 
Income taxes payable3,440 4,585 
Current portion of lease liabilities70,896 77,655 
Current portion of long-term debt94,578 141,749 
Dividends declared7,688  
Total Current Liabilities1,020,425 1,166,338 
Accrued Compensation and Related Benefits164,239 175,391 
Other Liabilities28,686 36,497 
Deferred Income Taxes670,512 676,706 
Mandatorily Redeemable Noncontrolling Interest25,149 13,661 
Lease Liabilities401,977 405,200 
Long-Term Debt511,574 525,752 
Total Liabilities2,822,562 2,999,545 
Commitments and Contingencies (Note 14)
Redeemable Noncontrolling Interests16,500 14,311 
Preferred Stock  
Common Stockholders’ Equity    
Common stock20,000 20,000 
Capital in excess of par value392,973 389,456 
Retained earnings7,131,747 7,126,761 
Accumulated other comprehensive income, net of taxes  
Cumulative foreign currency translation adjustment(48,964)(6,298)
Unrealized gain on pensions and other postretirement plans953,605 979,157 
Cash flow hedge633 (1,471)
Cost of Class B common stock held in treasury(4,141,303)(4,108,022)
Total Common Stockholders’ Equity4,308,691 4,399,583 
Noncontrolling Interests13,552 12,086 
Total Equity4,322,243 4,411,669 
Total Liabilities and Equity$7,161,305 $7,425,525 
See accompanying Notes to Condensed Consolidated Financial Statements.
3


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
  Six Months Ended 
 June 30
(in thousands)20222021
Cash Flows from Operating Activities    
Net Income$29,951 $228,561 
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and long-lived asset impairments68,689 65,786 
Amortization of lease right-of-use asset33,473 36,774 
Net pension benefit(90,971)(45,413)
Loss (gain) on marketable equity securities and cost method investments, net118,628 (165,257)
Gain on disposition of businesses, property, plant and equipment and investments, net(2,265)(15,080)
Provision for doubtful trade receivables2,218 2,506 
Stock-based compensation expense, net of forfeitures3,102 3,060 
Foreign exchange loss (gain)1,525 (680)
Equity in earnings of affiliates, net of distributions
2,036 (5,053)
Provision for deferred income taxes5,795 52,856 
Accretion expense and change in fair value of contingent consideration liabilities(2,655)(2,679)
Change in operating assets and liabilities:
Accounts receivable126,006 38,541 
Inventories(36,360)(4,971)
Accounts payable and accrued liabilities(37,455)(15,592)
Deferred revenue(59,558)(61,591)
Income taxes receivable/payable(8,284)10,681 
Lease liabilities(40,872)(41,655)
Other assets and other liabilities, net(15,834)(9,343)
Other2,239 1,394 
Net Cash Provided by Operating Activities99,408 72,845 
Cash Flows from Investing Activities    
Proceeds from sales of marketable equity securities74,233 37,629 
Purchases of property, plant and equipment(32,154)(27,502)
Purchases of marketable equity securities(31,468)(48,036)
Investments in equity affiliates, cost method and other investments
(27,950)(4,910)
Investments in certain businesses, net of cash acquired(3,053)(272,428)
Net proceeds from disposition of businesses, property, plant and equipment, and investments
2,324 4,735 
Return of investment in equity affiliates152 4 
Net Cash Used in Investing Activities(17,916)(310,508)
Cash Flows from Financing Activities    
Net payments under revolving credit facilities(47,000)(2,304)
Common shares repurchased(34,303) 
Dividends paid(15,465)(15,106)
Net proceeds from (repayments of) vehicle floor plan payable14,121 (9,591)
Repayments of borrowings(7,580)(2,071)
Proceeds from bank overdrafts6,073 4,433 
Deferred payments of acquisitions(4,731)(30,866)
Proceeds from exercise of stock options1,437  
Purchase of noncontrolling interest (3,508)
Issuance of borrowings 121 
Other(2,123)(283)
Net Cash Used in Financing Activities(89,571)(59,175)
Effect of Currency Exchange Rate Change(4,901)(684)
Net Decrease in Cash and Cash Equivalents and Restricted Cash(12,980)(297,522)
Beginning Cash and Cash Equivalents and Restricted Cash158,843 423,054 
Ending Cash and Cash Equivalents and Restricted Cash$145,863 $125,532 


See accompanying Notes to Condensed Consolidated Financial Statements.
4


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN COMMON STOCKHOLDERS’ EQUITY (UNAUDITED)
(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2021$20,000 $389,456 $7,126,761 $971,388 $(4,108,022)$12,086 $4,411,669 $14,311 
Net income for the period96,566 96,566 
Net income attributable to noncontrolling interests(986)986  
Net loss attributable to redeemable noncontrolling interests
44 44 (44)
Change in redemption value of redeemable noncontrolling interests64 64 64 
Distribution to noncontrolling interest(357)(357)
Dividends on common stock(15,497)(15,497)
Repurchase of Class B common stock(9,527)(9,527)
Issuance of Class B common stock1,437 1,437 
Amortization of unearned stock compensation and stock option expense1,677 1,677 
Other comprehensive loss, net of income taxes(13,135)(13,135)
As of March 31, 2022$20,000 $391,133 $7,206,888 $958,253 $(4,116,112)$12,779 $4,472,941 $14,331 
Net loss for the period(66,615)(66,615)
Noncontrolling interest capital contribution140 140 
Acquisition of noncontrolling interest
512 512 
Net income attributable to noncontrolling interests(929)929  
Acquisition of redeemable noncontrolling interest
 2,164 
Net loss attributable to redeemable noncontrolling interests59 59 (59)
Change in redemption value of redeemable noncontrolling interests64 64 64 
Distribution to noncontrolling interest(872)(872)
Dividends on common stock(7,656)(7,656)
Repurchase of Class B common stock(24,776)(24,776)
Forfeiture of restricted stock awards, net of Class B common stock issuances(462)(415)(877)
Amortization of unearned stock compensation and stock option expense2,302 2,302 
Other comprehensive loss, net of income taxes(52,979)(52,979)
As of June 30, 2022$20,000 $392,973 $7,131,747 $905,274 $(4,141,303)$13,552 $4,322,243 $16,500 
5


(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2020$20,000 $388,159 $6,804,822 $603,314 $(4,056,993)$7,091 $3,766,393 $11,928 
Net income for the period112,635 112,635 
Net income attributable to noncontrolling interests
(185)185  
Change in redemption value of redeemable noncontrolling interests
697 64 761 (634)
Distribution to noncontrolling interest(126)(126)
Dividends on common stock(15,106)(15,106)
Issuance of Class B common stock, net of restricted stock forfeitures(5,188)5,084 (104)
Amortization of unearned stock compensation and stock option expense
1,589 1,589 
Other comprehensive loss, net of income taxes
(1,203)(1,203)
Purchase of redeemable noncontrolling interest (3,508)
As of March 31, 2021$20,000 $385,257 $6,902,166 $602,111 $(4,051,909)$7,214 $3,864,839 $7,786 
Net income for the period115,926 115,926 
Net income attributable to noncontrolling interests
(699)699  
Net loss attributable to redeemable noncontrolling interests
131 131 (131)
Change in redemption value of redeemable noncontrolling interests
65 65 65 
Distribution to noncontrolling interest(152)(152)
Dividends on common stock(7,553)(7,553)
Forfeiture of restricted stock awards, net of Class B common stock issuances(47)(49)(96)
Amortization of unearned stock compensation and stock option expense
1,672 1,672 
Other comprehensive income, net of income taxes1,080 1,080 
As of June 30, 2021$20,000 $386,882 $7,009,971 $603,191 $(4,051,958)$7,826 $3,975,912 $7,720 

See accompanying Notes to Condensed Consolidated Financial Statements.
6


GRAHAM HOLDINGS COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. ORGANIZATION, BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS
Graham Holdings Company (the Company), is a diversified education and media company. The Company’s Kaplan subsidiary provides a wide variety of educational services, both domestically and outside the United States (U.S.). The Company’s media operations comprise the ownership and operation of seven television broadcasting stations, several websites and print publications, podcast content and a marketing solutions provider. The Company’s other business operations include manufacturing, automotive dealerships, consumer internet brands, restaurants and entertainment venues, custom framing services and home health and hospice services.
Basis of Presentation – The accompanying condensed consolidated financial statements have been prepared in accordance with: (i) generally accepted accounting principles in the United States of America (GAAP) for interim financial information; (ii) the instructions to Form 10-Q; and (iii) the guidance of Rule 10-01 of Regulation S-X under the Securities and Exchange Act of 1934, as amended, for financial statements required to be filed with the Securities and Exchange Commission (SEC). They include the assets, liabilities, results of operations and cash flows of the Company, including its domestic and foreign subsidiaries that are more than 50% owned or otherwise controlled by the Company. As permitted under such rules, certain notes and other financial information normally required by GAAP have been condensed or omitted. Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company’s financial position, results of operations, and cash flows as of and for the periods presented herein. The Company’s results of operations for the three and six months ended June 30, 2022 and 2021 may not be indicative of the Company’s future results. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.
The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.
Use of Estimates in the Preparation of the Condensed Consolidated Financial Statements – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported herein. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates.
The Company assessed certain accounting matters that generally require consideration of forecasted financial information, in context with the information reasonably available to the Company and the unknown future impacts of the novel coronavirus (COVID-19) pandemic as of June 30, 2022 and through the date of this filing. The accounting matters assessed included, but were not limited to, the Company’s carrying value of goodwill and other long-lived assets, allowance for doubtful accounts, inventory valuation and related reserves, fair value of financial assets, valuation allowances for tax assets and revenue recognition. These assessments had no impact on the Company’s condensed consolidated financial statements as of and for the six months ended June 30, 2022. The Company’s assessments as of and for the six months ended June 30, 2021 resulted in other long-lived asset impairment charges (see Note 8). The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company’s condensed consolidated financial statements in future reporting periods.
2. ACQUISITIONS AND DISPOSITIONS OF BUSINESSES
Acquisitions. On July 5, 2022, the Company’s automotive subsidiary acquired two automotive dealerships, including the real property for the dealership operations. In addition to a cash payment and the assumption of $10.9 million in floor plan payables, the automotive subsidiary borrowed $77.4 million to finance the acquisition. The dealerships are operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. These acquisitions expand the Company’s automotive business operations and will be included in automotive.
In May 2022, Graham Healthcare Group (GHG) acquired two small businesses which are included in healthcare.
During 2021, the Company acquired six businesses: two in education, two in healthcare, one in automotive, and one in other businesses for $392.4 million in cash and contingent consideration and the assumption of floor plan payables. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of the acquisition.
7


On June 14, 2021, the Company acquired all of the outstanding common shares of Leaf Group Ltd. (Leaf) for $308.6 million in cash and the assumption of $9.2 million in liabilities related to their previous stock compensation plan, which will be paid in the future. Leaf is a consumer internet company that builds creator-driven brands in lifestyle and home and art design categories. The acquisition is expected to provide benefits in the future by diversifying the Company’s business operations and providing operating synergies with other business units. The Company includes Leaf in other businesses.
Kaplan acquired certain assets of Projects in Knowledge, a continuing medical education provider for healthcare professionals, and another small business in November 2021. These acquisitions are expected to build upon Kaplan’s existing customer base in the medical and test preparation fields. Both business are included in Kaplan’s supplemental education division.
In December 2021, GHG acquired two businesses, a home health business in Florida and a 50.1% interest in Weiss, a physician practice specializing in allergies, asthma and immunology. The minority shareholder of Weiss has an option to put 10% of the shares to the Company annually starting in 2026 and may put all of the shares starting in 2033. The fair value of the redeemable noncontrolling interest in Weiss was $6.6 million at the acquisition date, determined using an income approach. These acquisitions are expected to expand the market the healthcare division serves and are included in healthcare.
On December 28, 2021, the Company’s automotive subsidiary acquired a Ford automotive dealership for cash and the assumption of $16.2 million in floor plan payables (see Note 5). In connection with the acquisition, the automotive subsidiary of the Company borrowed $22.5 million to finance the acquisition. The dealership is operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. The acquisition expands the Company’s automotive business operations and is included in automotive.
Acquisition-related costs for acquisitions that closed during the first six months of 2021 were $1.4 million and were expensed as incurred. The aggregate purchase price of the 2021 acquisitions was allocated as follows on a preliminary basis, based on acquisition date fair values to the following assets and liabilities:
Purchase Price Allocation
Year Ended
(in thousands)December 31, 2021
Accounts receivable$17,928 
Inventory25,383 
Property, plant and equipment13,126 
Lease right-of-use assets25,890 
Goodwill204,070 
Indefinite-lived intangible assets22,200 
Amortized intangible assets99,800 
Other assets4,911 
Deferred income taxes44,975 
Floor plan payables(16,198)
Other liabilities(52,760)
Current and noncurrent lease liabilities(25,593)
Redeemable noncontrolling interest(6,616)
Aggregate purchase price, net of cash acquired$357,116 
The 2021 fair values recorded were based upon preliminary valuations and the estimates and assumptions used in such valuations are subject to change within the measurement period (up to one year from the acquisition date). These values include measurement period adjustments related to accounts receivable, goodwill, amortized intangible assets, current and noncurrent lease liabilities, deferred income taxes and contingent consideration. The recording of deferred tax assets and liabilities, working capital and the amounts of residual goodwill are not yet finalized. Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The goodwill recorded due to these acquisitions is attributable to the assembled workforces of the acquired companies and expected synergies. The Company expects to deduct $80.0 million of goodwill for income tax purposes for the acquisitions completed in 2021.
The acquired companies were consolidated into the Company’s financial statements starting on their respective acquisition dates. The following unaudited pro forma financial information presents the Company’s results as if the
8


current year acquisitions had occurred at the beginning of 2021. The unaudited pro forma information also includes the 2021 acquisitions as if they occurred at the beginning of 2020:
Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2022202120222021
Operating revenues$934,076 $903,405 $1,851,383 $1,728,945 
Net (loss) income(66,299)113,875 31,152 225,206 
These pro forma results were based on estimates and assumptions, which the Company believes are reasonable, and include the historical results of operations of the acquired companies and adjustments for depreciation and amortization of identified assets and the effect of pre-acquisition transaction related expenses incurred by the Company and the acquired entities. The pro forma information does not include efficiencies, cost reductions and synergies expected to result from the acquisitions. They are not the results that would have been realized had these entities been part of the Company during the periods presented and are not necessarily indicative of the Company’s consolidated results of operations in future periods.
Other Transactions. In March 2021, Hoover’s minority shareholders put the remaining outstanding shares to the Company, which had a redemption value of $3.5 million. Following the redemption, the Company owns 100% of Hoover.
3. INVESTMENTS
Money Market Investments. As of June 30, 2022, the Company had money market investments of $17.8 million that are classified as cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheets. The Company had no money market investments as of December 31, 2021.
Investments in Marketable Equity Securities. Investments in marketable equity securities consist of the following:
  As of
June 30,
2022
December 31,
2021
(in thousands)
Total cost
$269,576 $273,201 
Gross unrealized gains
382,007 537,915 
Gross unrealized losses(2,979)(1,119)
Total Fair Value
$648,604 $809,997 
At June 30, 2022 and December 31, 2021, the Company owned 55,430 and 44,430 shares in Markel Corporation (Markel) valued at $71.7 million and $54.8 million, respectively. The Co-Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company’s Board of Directors. As of June 30, 2022, there was no marketable equity security holding that exceeded 5% of the Company’s total assets.
The Company purchased $31.5 million of marketable equity securities during the first six months of 2022. The Company purchased $48.0 million of marketable equity securities during the first six months of 2021.
During the first six months of 2022, the gross cumulative realized gains from the sales of marketable equity securities were $39.1 million. The total proceeds from such sales were $74.2 million. During the first six months of 2021, the gross cumulative realized gains from the sales of marketable equity securities were $27.7 million. The total proceeds from such sales were $37.6 million.
The net (loss) gain on marketable equity securities comprised the following:

Three Months Ended 
 June 30

Six Months Ended 
 June 30
(in thousands)
2022202120222021
(Loss) gain on marketable equity securities, net
$(165,540)$83,698 $(118,628)$162,912 
Less: Net losses (gains) in earnings from marketable equity securities sold and donated
4,838 (8,161)10,605 (8,161)
Net unrealized (losses) gains in earnings from marketable equity securities still held at the end of the period
$(160,702)

$75,537 

$(108,023)$154,751 
Investments in Affiliates. As of June 30, 2022, the Company held an approximate 12% interest in Intersection Holdings, LLC (Intersection), and accounts for its investment under the equity method. The Company holds two of the ten seats of Intersection’s governing board, which allows the Company to exercise significant influence over
9


Intersection. As of June 30, 2022, the Company also held investments in several other affiliates; GHG held a 40% interest in Residential Home Health Illinois, a 40% interest in Residential Hospice Illinois, a 40% interest in the joint venture formed between GHG and a Michigan hospital, and a 40% interest in the joint venture formed between GHG and Allegheny Health Network (AHN). During the first quarter of 2022, GHG invested an additional $18.5 million in the Residential Home Health Illinois and Residential Hospice Illinois affiliates to fund their acquisition of certain home health and hospice assets of the NorthShore University HealthSystem. The transaction diluted GHG’s interest in Residential Hospice Illinois resulting in a $0.6 million gain on the sale of investment in affiliate (see Note 12). For the three and six months ended June 30, 2022, the Company recorded $3.7 million and $7.0 million, respectively, in revenue for services provided to the affiliates of GHG. For the three and six months ended June 30, 2021, the Company recorded $2.7 million and $5.2 million, respectively, in revenue for services provided to the affiliates of GHG.
The Company had $54.3 million and $52.5 million in its investment account that represents cumulative undistributed income in its investments in affiliates as of June 30, 2022 and December 31, 2021, respectively.
Additionally, Kaplan International Holdings Limited (KIHL) held a 45% interest in a joint venture formed with University of York. KIHL loaned the joint venture £22 million, which loan is repayable over 25 years at an interest rate of 7% and guaranteed by the University of York. The loan is repayable by December 2041.
Cost Method Investments. The Company held investments without readily determinable fair values in a number of equity securities that are accounted for as cost method investments, which are recorded at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer. The carrying value of these investments was $52.3 million and $48.9 million as of June 30, 2022 and December 31, 2021, respectively. During the three and six months ended June 30, 2021, the Company recorded gains of $7.8 million and $10.5 million, respectively, to those equity securities based on observable transactions.
4. ACCOUNTS RECEIVABLE, ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Accounts receivable consist of the following:
As of
June 30,
2022
December 31,
2021
(in thousands)
Receivables from contracts with customers, less estimated credit losses of $22,093 and $21,836
$449,268 $589,582 
Other receivables26,065 17,889 
 $475,333 $607,471 
Credit loss expense was $0.7 million and $1.4 million for the three months ended June 30, 2022 and 2021, respectively. Credit loss expense was $2.2 million and $2.5 million for the six months ended June 30, 2022 and 2021, respectively.
Accounts payable and accrued liabilities consist of the following:
As of
June 30,
2022
December 31,
2021
(in thousands)
Accounts payable$143,196 $126,985 
Accrued compensation and related benefits155,031 179,307 
Other accrued liabilities261,895 277,337 
$560,122 $583,629 
Cash overdrafts of $11.6 million and $5.5 million are included in accounts payable as of June 30, 2022 and December 31, 2021, respectively.
10


5. INVENTORIES, CONTRACTS IN PROGRESS AND VEHICLE FLOOR PLAN PAYABLE
Inventories and contracts in progress consist of the following:
As of
June 30,
2022
December 31,
2021
(in thousands)
Raw materials$65,049 $54,944 
Work-in-process15,835 11,506 
Finished goods97,137 72,796 
Contracts in progress259 2,225 
 $178,280 $141,471 
The Company finances new, used and service loaner vehicle inventory through standardized floor plan facilities with Truist Bank (Truist floor plan facility) and Ford Motor Credit Company (Ford floor plan facility). The Truist floor plan facility bears interest at variable rates that are based on Secured Overnight Financing Rate (SOFR) plus 1.19% per annum. The Ford floor plan facility bears interest at variable interest rates that are based on the prime rate, with a floor of 3.5%, plus 1.5% per annum. The weighted average interest rate for the floor plan facilities was 2.2% and 1.2% for the three months ended June 30, 2022 and 2021, respectively. The weighted average interest rate for the floor plan facilities was 2.1% and 1.2% for the six months ended June 30, 2022 and 2021, respectively. As of June 30, 2022, the aggregate capacity under the floor plan facilities was $70.9 million, of which $45.7 million had been utilized, and is included in accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheet. Changes in the vehicle floor plan payable are reported as cash flows from financing activities in the Condensed Consolidated Statements of Cash Flows.
The floor plan facilities are collateralized by vehicle inventory and other assets of the relevant dealership subsidiary, and contains a number of covenants, including, among others, covenants restricting the dealership subsidiary with respect to the creation of liens and changes in ownership, officers and key management personnel. The Company was in compliance with all of these restrictive covenants as of June 30, 2022.
The floor plan interest expense related to the vehicle floor plan arrangements is offset by amounts received from manufacturers in the form of floor plan assistance capitalized in inventory and recorded against cost of goods sold in the Condensed Consolidated Statements of Operations when the associated inventory is sold. For the three months ended June 30, 2022 and 2021, the Company recognized a reduction in cost of goods sold of $1.1 million and $0.8 million, respectively, related to manufacturer floor plan assistance. For the six months ended June 30, 2022 and 2021, the Company recognized a reduction in cost of goods sold of $2.0 million and $1.4 million, respectively, related to manufacturer floor plan assistance.
6. GOODWILL AND OTHER INTANGIBLE ASSETS
Amortization of intangible assets for the three months ended June 30, 2022 and 2021, was $14.9 million and $13.9 million, respectively. Amortization of intangible assets for the six months ended June 30, 2022 and 2021, was $29.8 million and $27.8 million, respectively. Amortization of intangible assets is estimated to be approximately $29 million for the remainder of 2022, $51 million in 2023, $39 million in 2024, $31 million in 2025, $26 million in 2026 and $41 million thereafter. The changes in the carrying amount of goodwill, by segment, were as follows:
(in thousands)EducationTelevision
Broadcasting
ManufacturingHealthcareAutomotiveOther
Businesses
Total
Balance as of December 31, 2021        
Goodwill$1,186,236 $190,815 $234,993 $118,329 $45,826 $253,399 $2,029,598 
Accumulated impairment losses
(331,151) (34,302)  (14,563)(380,016)
855,085 190,815 200,691 118,329 45,826 238,836 1,649,582 
Measurement period adjustments
1,000   250  (2,183)(933)
Acquisitions   5,971   5,971 
Foreign currency exchange rate changes
(36,972)     (36,972)
Balance as of June 30, 2022        
Goodwill1,150,264 190,815 234,993 124,550 45,826 251,216 1,997,664 
Accumulated impairment losses
(331,151) (34,302)  (14,563)(380,016)
$819,113 $190,815 $200,691 $124,550 $45,826 $236,653 $1,617,648 
11


The changes in carrying amount of goodwill at the Company’s education division were as follows:
(in thousands)Kaplan
International
Higher
Education
Supplemental EducationTotal
Balance as of December 31, 2021      
Goodwill$621,268 $174,564 $390,404 $1,186,236 
Accumulated impairment losses (111,324)(219,827)(331,151)
621,268 63,240 170,577 855,085 
Measurement period adjustments  1,000 1,000 
Foreign currency exchange rate changes(36,962) (10)(36,972)
Balance as of June 30, 2022      
Goodwill584,306 174,564 391,394 1,150,264 
Accumulated impairment losses (111,324)(219,827)(331,151)
$584,306 $63,240 $171,567 $819,113 
Other intangible assets consist of the following:
As of June 30, 2022As of December 31, 2021
(in thousands)Useful Life
Range
Gross
Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
 Carrying
Amount
Amortized Intangible Assets              
Student and customer relationships
210 years
$297,886 $218,349 $79,537 $300,027 $206,714 $93,313 
Trade names and trademarks
215 years
158,006 75,092 82,914 158,365 68,113 90,252 
Databases and technology
36 years
36,186 29,309 6,877 36,585 26,464 10,121 
Network affiliation agreements
10 years
17,400 9,497 7,903 17,400 8,628 8,772 
Noncompete agreements
25 years
1,000 993 7 1,000 991 9 
Other
18 years
68,900 29,526 39,374 68,500 23,847 44,653 
    $579,378 $362,766 $216,612 $581,877 $334,757 $247,120 
Indefinite-Lived Intangible Assets
              
Trade names and trademarks  $82,316     $86,972     
Franchise agreements44,058 44,058 
FCC licenses11,000 11,000 
Licensure and accreditation  150     150     
Other21  
  $137,545 $142,180 
7. DEBT
The Company’s borrowings consist of the following:
  As of
(in thousands)MaturitiesStated Interest RateEffective Interest RateJune 30,
2022
December 31,
2021
Unsecured notes (1)
20265.75%5.75%$397,186 $396,830 
Revolving credit facility2027
1.61% - 4.38%
2.00%150,804 209,643 
Truist Bank commercial note (2)
2031
1.85% - 2.72%
2.16%24,013 24,504 
Truist Bank commercial note2032
2.10% - 2.97%
2.41%21,563 22,500 
Pinnacle Bank term loan20244.15%4.19%8,996 9,558 
Other indebtedness2025 - 2030
0.00% - 16.00%
3,590 4,466 
Total Debt606,152 667,501 
Less: current portion(94,578)(141,749)
Total Long-Term Debt$511,574 $525,752 
____________
(1)     The carrying value is net of $2.8 million and $3.2 million of unamortized debt issuance costs as of June 30, 2022 and December 31, 2021, respectively.
(2)     The carrying value is net of $0.1 million of unamortized debt issuance costs as of June 30, 2022 and December 31, 2021.
At June 30, 2022 and December 31, 2021, the fair value of the Company’s 5.75% unsecured notes, based on quoted market prices (Level 2 fair value assessment), totaled $394.5 million and $417.5 million, respectively.
12


On May 3, 2022, the Company amended the revolving credit facility to, among other things, (i) extend the maturity of the facility to May 30, 2027, (ii) eliminate borrowings under separate U.S. Dollar and multicurrency tranches, (iii) update certain interest rate benchmarks including replacing USD London Interbank Offered Rate (LIBOR) with SOFR for borrowings denominated in U.S. dollars, (iv) incorporate a sub-facility for the issuance of letters of credit, and (v) allow for applicable margin for borrowings to be determined and adjusted quarterly based on the Company’s Total Net Leverage Ratio. The outstanding balance on the Company’s $300 million unsecured revolving credit facility was $150.8 million as of June 30, 2022, consisting of U.S. dollar borrowings of $90 million with interest payable at SOFR plus 1.375%, and British Pound (GBP) borrowings of £50 million with interest payable at Daily Sterling Overnight Index Average (SONIA) plus 1.375%.
The fair value of the Company’s other debt, which is based on Level 2 inputs, approximates its carrying value as of June 30, 2022 and December 31, 2021. The Company is in compliance with all financial covenants of the revolving credit facility, commercial notes, and Pinnacle Bank term loan as of June 30, 2022.
During the three months ended June 30, 2022 and 2021, the Company had average borrowings outstanding of approximately $638.3 million and $525.5 million, respectively, at average annual interest rates of approximately 4.7% and 4.9%, respectively. During the three months ended June 30, 2022 and 2021, the Company incurred net interest expense of $15.3 million and $5.5 million, respectively.
During the six months ended June 30, 2022 and 2021, the Company had average borrowings outstanding of approximately $648.8 million and $520.0 million, respectively, at average annual interest rates of approximately 4.5% and 5.0%, respectively. During the six months ended June 30, 2022 and 2021, the Company incurred net interest expense of $26.0 million and $13.0 million, respectively.
During the three and six months ended June 30, 2022, the Company recorded interest expense of $8.0 million and $11.4 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. During the three and six months ended June 30, 2021, the Company recorded interest income of $1.0 million and net interest expense of $0.1 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. The fair value of the mandatorily redeemable noncontrolling interest was based on the fair value of the underlying subsidiaries owned by GHC One, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined by reference to either a discounted cash flow or EBITDA multiple, which approximates fair value (Level 3 fair value assessment).
13


8. FAIR VALUE MEASUREMENTS
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:
As of June 30, 2022
(in thousands)Level 1Level 2Level 3Total
Assets      
Money market investments (1) 
$ $17,773 $ $17,773 
Marketable equity securities (2)
648,604   648,604 
Other current investments (3)
7,890 6,337  14,227 
Interest rate swap (4) 
 610  610 
Total Financial Assets
$656,494 $24,720 $ $681,214 
Liabilities
  
  
  
Contingent consideration liabilities (5)
$ $ $10,873 $10,873 
Mandatorily redeemable noncontrolling interest (6)
  25,149 25,149 
Total Financial Liabilities
$ $ $36,022 $36,022 

As of December 31, 2021
(in thousands)Level 1Level 2Level 3Total
Assets
  
  

  
Marketable equity securities (2)
$809,997 $ $ $809,997 
Other current investments (3)
7,230 7,218  14,448 
Total Financial Assets
$817,227 $7,218 $ $824,445 
Liabilities
  
  

  
Contingent consideration liabilities (5)
$ $ $14,881 $14,881 
Interest rate swap (7) 
 2,049  2,049 
Foreign exchange swap (8)
 484  484 
Mandatorily redeemable noncontrolling interest (6)
  13,661 13,661 
Total Financial Liabilities
$ $2,533 $28,542 $31,075 
____________
(1)
The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)
The Company’s investments in marketable equity securities are held in common shares of U.S. corporations that are actively traded on U.S. stock exchanges. Price quotes for these shares are readily available.
(3)
Includes U.S. Government Securities, corporate bonds, mutual funds and time deposits. These investments are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments and are classified as either Level 1 or Level 2 in the fair value hierarchy.
(4)
Included in Deferred Charges and Other Assets. The Company utilized a market approach model using the notional amount of the interest rate swap multiplied by the observable inputs of time to maturity and market interest rates.
(5)
Included in Accounts payable and accrued liabilities and Other Liabilities. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.
(6)
The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.
(7)
Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swap multiplied by the observable inputs of time to maturity and market interest rates.
(8)
Included in Accounts payable and accrued liabilities, and valued based on a valuation model that calculates the differential between the contract price and the market-based forward rate.

14


The following tables provide a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2021
$14,881 $13,661 
Acquisition of business397  
Changes in fair value (1)
(3,317)11,430 
Capital contributions
 242 
Accretion of value included in net income (1)
662  
Settlements or distributions
(1,750)(184)
As of June 30, 2022
$10,873 $25,149 
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2020$37,174 $9,240 
Changes in fair value (1)
(3,720)96 
Capital contributions
 37 
Accretion of value included in net income (1)
1,041  
Settlements or distributions
(19,836)(41)
Foreign currency exchange rate changes
34  
As of June 30, 2021$14,693 $9,332 
____________
(1)Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Condensed Consolidated Statements of Operations.
During the three and six months ended June 30, 2021, the Company recorded other long-lived asset impairment charges of $3.8 million and $4.8 million, respectively. The remeasurement of the other long-lived assets is classified as a Level 3 fair value assessment due to the significance of unobservable inputs developed in the determination of the fair value. The Company used a discounted cash flow model to determine the estimated fair value of the other long-lived assets. A market value approach was also utilized to supplement the discounted cash flow model. The Company made estimates and assumptions regarding future cash flows, discount rates and market values.
During the three and six months ended June 30, 2021, the Company recorded gains of $7.8 million and $10.5 million, respectively, to equity securities that are accounted for as cost method investments based on observable transactions for identical or similar investments of the same issuer.
9. REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company generated 79% of its revenue from U.S. domestic sales for the three and six months ended June 30, 2022. The remaining 21% of revenue was generated from non-U.S. sales for the three and six months ended June 30, 2022. For the three and six months ended June 30, 2021, 78% and 77% of revenue was from U.S. domestic sales and the remaining 22% and 23% of revenue was generated from non-U.S. sales.
For the three and six months ended June 30, 2022, the Company recognized 60% of its revenue over time as control of the services and goods transferred to the customer, and the remaining 40% at a point in time, when the customer obtained control of the promised goods. For the three and six months ended June 30, 2021, the Company recognized 66% and 68% of its revenue over time, and the remaining 34% and 32% at a point in time.
Contract Assets. As of June 30, 2022, the Company recognized a contract asset of $19.0 million related to a contract at a Kaplan International business, which is included in Deferred Charges and Other Assets. The Company expects to recognize an additional $456.1 million related to this performance obligation within the next ten years. As of December 31, 2021, the contract asset was $17.7 million.
Deferred Revenue. The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance, including amounts which are refundable. The following table presents the change in the Company’s deferred revenue balance:
As of
June 30,
2022
December 31,
2021
%
(in thousands)Change
Deferred revenue$287,681 $363,065 (21)
15


In April 2020, GHG received $31.5 million under the expanded Medicare Accelerated and Advanced Payment Program modified by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) as a result of COVID-19. The Department of Health and Human Services started to recoup this advance 365 days after the payment was issued. GHG recognized $5.6 million and $12.0 million of the balance in revenue for claims submitted for eligible services for the three and six months ended June 30, 2022, respectively. The remaining balance of $0.5 million is included in the current deferred revenue balance on the Condensed Consolidated Balance Sheet as of June 30, 2022. For the three and six months ended June 30, 2021, GHG recognized $5.0 million of the balance in revenue for claims submitted for eligible services.
The majority of the change in the deferred revenue balance is related to the cyclical nature of services in the Kaplan international division. During the six months ended June 30, 2022, the Company recognized $271.9 million related to the Company’s deferred revenue balance as of December 31, 2021.
Revenue allocated to remaining performance obligations represents deferred revenue amounts that will be recognized as revenue in future periods. As of June 30, 2022, the deferred revenue balance related to certain medical and nursing qualifications with an original contract length greater than twelve months at Kaplan Supplemental Education was $7.7 million. Kaplan Supplemental Education expects to recognize 75% of this revenue over the next twelve months and the remainder thereafter.
Costs to Obtain a Contract. The following table presents changes in the Company’s costs to obtain a contract asset:
(in thousands)Balance at
Beginning
of Period
Costs associated with new contractsLess: Costs amortized during the periodOtherBalance
at
End of
Period
2022$26,081 $20,991 $(28,911)$(1,733)$16,428 
The majority of other activity was related to currency translation adjustments for the six months ended June 30, 2022.
10. (LOSS) EARNINGS PER SHARE
The Company’s unvested restricted stock awards contain nonforfeitable rights to dividends and, therefore, are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. The diluted earnings per share computed under the two-class method is lower than the diluted earnings per share computed under the treasury stock method, resulting in the presentation of the lower amount in diluted earnings per share. The computation of the earnings per share under the two-class method excludes the income attributable to the unvested restricted stock awards from the numerator and excludes the dilutive impact of those underlying shares from the denominator.
16


The following reflects the Company’s net (loss) income and share data used in the basic and diluted (loss) earnings per share computations using the two-class method:
Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands, except per share amounts)2022202120222021
Numerator:
Numerator for basic (loss) earnings per share:        
Net (loss) income attributable to Graham Holdings Company common stockholders
$(67,485)$115,358 $28,139 $227,808 
Less: Dividends-common stock outstanding and unvested restricted shares
(7,656)(7,553)(23,153)(22,659)
Undistributed (loss) earnings(75,141)107,805 4,986 205,149 
Percent allocated to common stockholders (1)
100.00 %99.34 %99.40 %99.34 %
(75,141)107,089 4,956 203,786 
Add: Dividends-common stock outstanding7,610 7,503 23,016 22,508 
Numerator for basic (loss) earnings per share$(67,531)$114,592 $27,972 $226,294 
Add: Additional undistributed earnings due to dilutive stock options
 2  4 
Numerator for diluted (loss) earnings per share$(67,531)$114,594 $27,972 $226,298 
Denominator:    
Denominator for basic (loss) earnings per share:
Weighted average shares outstanding4,842 4,968 4,857 4,968 
Add: Effect of dilutive stock options 17 13 13 
Denominator for diluted (loss) earnings per share4,842 4,985 4,870 4,981 
Graham Holdings Company Common Stockholders:        
Basic (loss) earnings per share
$(13.95)$23.07 $5.76 $45.55 
Diluted (loss) earnings per share
$(13.95)$22.99 $5.74 $45.43 
____________
(Loss) earnings per share amounts may not recalculate due to rounding.
(1)    Percent of undistributed losses allocated to common stockholders is 100% in the three months ended June 30, 2022 as participating securities are not contractually obligated to share in losses.
Diluted (loss) earnings per share excludes the following weighted average potential common shares, as the effect would be antidilutive, as computed under the treasury stock method:
Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2022202120222021
Weighted average restricted stock17 13 17 10 
Weighted average stock options13    
The diluted (loss) earnings per share amounts for the three and six months ended June 30, 2022 and June 30, 2021 exclude the effects of 105,000 and 104,000 stock options and contingently issuable shares outstanding, respectively, as their inclusion would have been antidilutive due to a market condition.
In the three and six months ended June 30, 2022, the Company declared regular dividends totaling $1.58 and $4.74 per common share, respectively. In the three and six months ended June 30, 2021, the Company declared regular dividends totaling $1.51 and $4.53 per common share, respectively.
17


11. PENSION AND POSTRETIREMENT PLANS
Defined Benefit Plans. The total benefit arising from the Company’s defined benefit pension plans consists of the following components:
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2022202120222021
Service cost$4,993 $5,877 $11,024 $11,479 
Interest cost7,611 6,754 15,281 13,408 
Expected return on assets(41,963)(33,702)(83,926)(68,278)
Amortization of prior service cost709 712 1,418 1,423 
Recognized actuarial gain(17,539)(1,671)(34,768)(4,563)
Net Periodic Benefit(46,189)(22,030)(90,971)(46,531)
Special separation benefit expense
 1,118  1,118 
Total Benefit$(46,189)$(20,912)$(90,971)$(45,413)
In the second quarter of 2021, the Company recorded $1.1 million in expenses related to a Separation Incentive Program for certain Dekko employees, which was funded from the assets of the Company’s pension plan.
The total cost arising from the Company’s Supplemental Executive Retirement Plan (SERP) consists of the following components:
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2022202120222021
Service cost$228 $256 $456 $511 
Interest cost822 735 1,644 1,471 
Amortization of prior service cost9 82 18 165 
Recognized actuarial loss167 1,483 333 2,965 
Net Periodic Cost$1,226 $2,556 $2,451 $5,112 
Defined Benefit Plan Assets. The Company’s defined benefit pension obligations are funded by a portfolio made up of private investment funds, a U.S. stock index fund, and a relatively small number of stocks and high-quality fixed-income securities that are held by a third-party trustee. The assets of the Company’s pension plans were allocated as follows:
  As of
  June 30,
2022
December 31,
2021
  
U.S. equities63 %61 %
Private investment funds16 %17 %
U.S. stock index fund8 %9 %
International equities8 %9 %
U.S. fixed income5 %4 %
  100 %100 %
The Company manages approximately 40% of the pension assets internally, of which the majority is invested in private investment funds with the remaining investments in Berkshire Hathaway stock, a U.S. stock index fund, and short-term fixed-income securities. The remaining 60% of plan assets are managed by two investment companies. The goal of the investment managers is to produce moderate long-term growth in the value of these assets, while protecting them against large decreases in value. Both investment managers may invest in a combination of equity and fixed-income securities and cash. The managers are not permitted to invest in securities of the Company or in alternative investments. One investment manager cannot invest more than 15% of the assets at the time of purchase in the stock of Alphabet and Berkshire Hathaway, and no more than 30% of the assets it manages in specified international exchanges at the time the investment is made. The other investment manager cannot invest more than 20% of the assets at the time of purchase in the stock of Berkshire Hathaway, and no more than 15% of the assets it manages in specified international exchanges at the time the investment is made, and no less than 10% of the assets could be invested in fixed-income securities. Excluding the exceptions noted above, the investment managers cannot invest more than 10% of the assets in the securities of any other single issuer, except for obligations of the U.S. Government, without receiving prior approval from the Plan administrator.
In determining the expected rate of return on plan assets, the Company considers the relative weighting of plan assets, the historical performance of total plan assets and individual asset classes and economic and other
18


indicators of future performance. In addition, the Company may consult with and consider the input of financial and other professionals in developing appropriate return benchmarks.
The Company evaluated its defined benefit pension plan asset portfolio for the existence of significant concentrations (defined as greater than 10% of plan assets) of credit risk as of June 30, 2022. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country and individual fund. At June 30, 2022, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $782.4 million, or approximately 31% of total plan assets. At December 31, 2021, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $998.8 million, or approximately 29% of total plan assets.
Other Postretirement Plans. The total benefit arising from the Company’s other postretirement plans consists of the following components:
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2022202120222021
Interest cost$25 $10 $49 $46 
Amortization of prior service credit(2)(2)(4)(4)
Recognized actuarial gain(710)(736)(1,421)(1,755)
Net Periodic Benefit$(687)$(728)$(1,376)$(1,713)
12. OTHER NON-OPERATING INCOME
A summary of non-operating income is as follows:

Three Months Ended 
 June 30

Six Months Ended 
 June 30
(in thousands)
2022202120222021
Gain on sale of businesses$753 $644 $1,698 $1,446 
Foreign currency (loss) gain, net(478)677 (1,525)680 
(Loss) gain on sale of cost method investments(51)6,699 1,024 6,793 
Gain on sale of investment in affiliate
  604  
Gain on cost method investments
 7,783  10,506 
Other gain, net
952 319 2,251 3,017 
Total Other Non-Operating Income
$1,176 $16,122 $4,052 $22,442 
The gains on cost method investments result from observable price changes in the fair value of the underlying equity securities accounted for under the cost method (see Notes 3 and 8).
During the three and six months ended June 30, 2022, the Company recorded contingent consideration gains of $0.8 million and $1.7 million, respectively, related to the disposition of Kaplan University (KU) in 2018. During the three and six months ended June 30, 2021, the Company recorded contingent consideration gains of $0.6 million and $1.5 million, respectively.
19


13. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The other comprehensive (loss) income consists of the following components:
Three Months Ended June 30
  20222021
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$(40,928)$ $(40,928)$1,167 $ $1,167 
Pension and other postretirement plans:            
Amortization of net prior service cost included in net income
716 (185)531 792 (214)578 
Amortization of net actuarial gain included in net income
(18,082)4,660 (13,422)(924)249 (675)
(17,366)4,475 (12,891)(132)35 (97)
Cash flow hedge:            
Gain for the period1,091 (251)840 13 (3)10 
Other Comprehensive (Loss) Income$(57,203)$4,224 $(52,979)$1,048 $32 $1,080 
  Six Months Ended June 30
  20222021
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$(42,666)$ $(42,666)$681 $ $681 
Pension and other postretirement plans:            
Amortization of net prior service cost included in net income
1,432 (369)1,063 1,584 (427)1,157 
Amortization of net actuarial gain included in net income
(35,856)9,241 (26,615)(3,353)905 (2,448)
  (34,424)8,872 (25,552)(1,769)478 (1,291)
Cash flow hedge:          
Gain for the period2,733 (629)2,104 634 (147)487 
Other Comprehensive Loss$(74,357)$8,243 $(66,114)$(454)$331 $(123)
The accumulated balances related to each component of other comprehensive income (loss) are as follows:
(in thousands, net of taxes)Cumulative
Foreign
Currency
Translation
Adjustment
Unrealized Gain
on Pensions
and Other
Postretirement
Plans
Cash Flow
Hedge
Accumulated
Other
Comprehensive
Income
Balance as of December 31, 2021$(6,298)$979,157 $(1,471)$971,388 
Other comprehensive (loss) income before reclassifications
(42,666) 1,769 (40,897)
Net amount reclassified from accumulated other comprehensive income (loss)
 (25,552)335 (25,217)
Other comprehensive (loss) income, net of tax
(42,666)(25,552)2,104 (66,114)
Balance as of June 30, 2022$(48,964)$953,605 $633 $905,274 
20


The amounts and line items of reclassifications out of Accumulated Other Comprehensive Income (Loss) are as follows:
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
Affected Line Item in the Condensed Consolidated Statements of Operations
  
(in thousands)2022202120222021
Pension and Other Postretirement Plans:        
Amortization of net prior service cost$716 $792 $1,432 $1,584 (1)
Amortization of net actuarial gain(18,082)(924)(35,856)(3,353)(1)
  (17,366)(132)(34,424)(1,769)Before tax
  4,475 35 8,872 478 (Benefit from) Provision for Income Taxes
  (12,891)(97)(25,552)(1,291)Net of Tax
Cash Flow Hedge151 153 335 307 Interest expense
Total reclassification for the period$(12,740)$56 $(25,217)$(984)Net of Tax
____________
(1)    These accumulated other comprehensive income components are included in the computation of net periodic pension and postretirement plan cost (see Note 11) and are included in non-operating pension and postretirement benefit income in the Company’s Condensed Consolidated Statements of Operations.
14. CONTINGENCIES
Litigation, Legal and Other Matters.  The Company and its subsidiaries are subject to complaints and administrative proceedings and are defendants in various civil lawsuits that have arisen in the ordinary course of their businesses, including contract disputes; actions alleging negligence, libel, defamation and invasion of privacy; trademark, copyright and patent infringement; violations of employment laws and applicable wage and hour laws; and statutory or common law claims involving current and former students and employees. Although the outcomes of the legal claims and proceedings against the Company cannot be predicted with certainty, based on currently available information, management believes that there are no existing claims or proceedings that are likely to have a material effect on the Company’s business, financial condition, results of operations or cash flows. However, based on currently available information, management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $15 million.
In 2015, Kaplan sold substantially all of the assets of the KHE Campuses (KHEC) business to Education Corporation of America. In 2018, certain subsidiaries of Kaplan contributed the institutional assets and operations of KU to a new university: an Indiana nonprofit, public-benefit corporation affiliated with Purdue University, known as Purdue University Global. Kaplan could be held liable to the current owners of KU and the KHEC schools related to the pre-sale conduct of the schools, and the pre-sale conduct of the schools has been and could be the subject of future compliance reviews, regulatory proceedings or lawsuits that could result in monetary liabilities or fines or other sanctions. On May 6, 2021, Kaplan received a notice from the Department of Education (ED) that it would be conducting a fact-finding process pursuant to the borrower defense to repayment (BDTR) regulations to determine the validity of more than 800 BDTR claims and a request for documents related to several of Kaplan’s previously owned schools. Beginning in July 2021, Kaplan started receiving the claims and related information requests. In total, Kaplan received 1,449 borrower defense applications that seek discharge of approximately $35 million in loans (excluding interest). Most claims received are from former KU students. The ED’s process for adjudicating these claims is subject to the borrower defense regulations but it is not clear to what extent the ED will exclude claims based on the underlying statutes of limitations, evidence provided by Kaplan, or any prior investigation related to schools attended by the student applicants.
On June 22, 2022, the ED filed a joint motion for approval of a settlement agreement in Sweet, et al. vs. Cardona, a case pending in the United States District Court for the Northern District of California. Kaplan is not a party to this case. This case was brought in 2019 by a purported class of borrowers demanding that the ED adjudicate all pending borrower defense claims. The settlement proposes that the ED will discharge the loans for students who borrowed to attend any school on a specified list. The list includes approximately 150 schools, including Bauder College, Mount Washington College, Kaplan Career Institute and Kaplan College, as well as Purdue University Global (encompassing the former Kaplan University). This proposed settlement would cover all claims to which Kaplan has previously responded to the ED and may also include new claims for which Kaplan has not received any information or which may still be filed prior to any final approval of the settlement by the court. ED has clarified that while attendance at one of the listed schools justifies presumptive relief for the borrowers, inclusion on the list is not a finding of misconduct by the school and does not provide an evidentiary basis upon which ED could rely to take action against any of the schools. In its July 25, 2022 filing, the ED stated that the proposed settlement in Sweet “creates no independent basis for action against the schools” and “any concrete consequences on the schools – financial or otherwise—could be imposed only after the ED initiates a separate, future proceeding...” The proposed settlement agreement will not be effective unless and until it achieves final court approval; a hearing on the
21


preliminary settlement approval is scheduled for later in August 2022. In the event the settlement is approved, the ED will likely be required to separately fully adjudicate the borrowers’ claims under the borrower defense rules process if it wishes to ultimately apply liability to institutions and seek recoupment of discharged amounts.
In any such process Kaplan believes it has defenses that would bar any student discharge or school liability including that the claims are barred by the applicable statute of limitations, unproven, incomplete and fail to meet regulatory filing requirements. Kaplan will vigorously defend any attempt by the ED to hold Kaplan liable for any ultimate student discharges and is responding to all claims with documentary and narrative evidence to refute the allegations, demonstrate their lack of merit, and support the denial of all such claims by the ED. If the ED grants borrower claims through the BTDR process, the ED may seek reimbursement for the amount discharged from Kaplan. If the ED were to initiate a recoupment action against Kaplan, and that action successfully overcame Kaplan’s defenses, Kaplan could be subject to significant liability.
On July 6, 2022 the ED released the draft Borrower Defense to Repayment rule for comment with the intention of publishing a final rule by November 1, 2022 with an effective date of July 1, 2023. Compared to the previous rule, this new rule in part, would expand actions that can give rise to claims for discharge; provides that the borrower’s claim will be presumed true if the institution does not provide any responsive evidence; provides an easier process for group claims; and relies on current program review penalty hearing processes for discharge recoupment. Under the proposed rule, the recoupment process applies only to loans first disbursed after July 1, 2023; however, the discharge process and standards apply to any pending application regardless of loan date.
In August 2018, Purdue University Global received an updated Provisional Program Participation Agreement (PPPA) from the ED which is necessary for continued participation in the federal Title IV programs after the change in ownership from Kaplan to Purdue. The PPPA expired on June 30, 2021 but was extended to June 30, 2022. Purdue Global submitted its renewed application for recertification in March 2022 which is pending review. The PPPA remains in effect as it is automatically extended on a month to month basis until the ED takes action to approve a full Program Participation Agreement.
In June 2021, the Committee for Private Education (CPE) in Singapore instructed Kaplan Singapore to cease new enrollments for three marketing diploma programs on both a full and part-time basis due to noncompliance with minimum entry level requirements for admission and to teach out existing students in these programs. On August 23, 2021, the CPE issued the same instructions with respect to the Kaplan Foundation diploma and four information technology diploma programs on both a full and part-time basis. In November 2021, the CPE issued the same instructions with respect to a further 23 full-time or part-time diploma programs. Post regulatory action, Kaplan Singapore was still able to offer 449 programs that remained registered with the CPE, out of which there were 16 diplomas, 361 bachelors and the balance of which were certificate and postgraduate courses. In April 2022, Kaplan Singapore applied for re-registration for certain of the diploma programs and in July 2022 received approval from the CPE. In May 2022, CPE also renewed Kaplan Singapore’s registrations as a private education institution for a four year period expiring in 2026. While the regulatory actions by the CPE in 2021 will have a significant adverse impact on Kaplan Singapore’s revenues, operating results and cash flows in the future, the impact is expected to be mitigated as a result of the recently approved registrations of certain impacted programs.
22


15. BUSINESS SEGMENTS
The Company has seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, Manufacturing, Healthcare and Automotive.
The following tables summarize the financial information related to each of the Company’s business segments:
  Three months endedSix months ended
June 30June 30
(in thousands)2022202120222021
Operating Revenues    
Education$353,013 $339,984 $711,025 $669,301 
Television broadcasting122,386 119,966 245,805 233,591 
Manufacturing127,062 141,123 243,002 257,083 
Healthcare76,385 54,696 143,640 104,739 
Automotive147,602 90,273 298,569 158,000 
Other businesses107,326 55,626 206,943 91,938 
Corporate office    
Intersegment elimination(472)(516)(961)(1,045)
  $933,302 $801,152 $1,848,023 $1,513,607 
Income (Loss) from Operations before Amortization of Intangible Assets and Impairment of Long-Lived Assets






Education$22,769 $19,221 $47,327 $43,369 
Television broadcasting41,042 36,964 82,300 71,301 
Manufacturing9,666 19,038 24,804 34,932 
Healthcare7,250 9,375 14,538 17,296 
Automotive7,365 3,785 14,443 4,309 
Other businesses(23,031)(18,565)(50,461)(37,781)
Corporate office(10,844)(14,570)(23,851)(29,350)
$54,217 $55,248 $109,100 $104,076 
Amortization of Intangible Assets and Impairment of Long-Lived Assets
Education$4,064 $6,073 $8,210 $11,285 
Television broadcasting1,360 1,361 2,720 2,720 
Manufacturing5,164 6,610 10,327 13,597 
Healthcare988 780 1,917 1,561 
Automotive    
Other businesses3,313 2,833 6,627 3,478 
Corporate office    
$14,889 $17,657 $29,801 $32,641 
Income (Loss) from Operations
Education$18,705 $13,148 $39,117 $32,084 
Television broadcasting39,682 35,603 79,580 68,581 
Manufacturing4,502 12,428 14,477 21,335 
Healthcare6,262 8,595 12,621 15,735 
Automotive7,365 3,785 14,443 4,309 
Other businesses(26,344)(21,398)(57,088)(41,259)
Corporate office(10,844)(14,570)(23,851)(29,350)
  $39,328 $37,591 $79,299 $71,435 
Equity in Earnings of Affiliates, Net1,427 1,776 4,031 15,204 
Interest Expense, Net(15,277)(5,477)(25,979)(13,035)
Non-Operating Pension and Postretirement Benefit Income, Net
50,871 25,216 101,376 54,003 
(Loss) Gain on Marketable Equity Securities, Net
(165,540)83,698 (118,628)162,912 
Other Income, Net
1,176 16,122 4,052 22,442 
(Loss) Income Before Income Taxes
$(88,015)$158,926 $44,151 $312,961 
23


  Three months endedSix months ended
June 30June 30
(in thousands)2022202120222021
Depreciation of Property, Plant and Equipment
Education$8,531 $7,482 $17,036 $15,262 
Television broadcasting3,085 3,543 6,374 7,016 
Manufacturing2,323 2,427 4,751 4,944 
Healthcare455 331 865 648 
Automotive752 490 1,529 1,020 
Other businesses4,114 2,169 8,029 3,929 
Corporate office153 158 304 326 
  $19,413 $16,600 $38,888 $33,145 
Pension Service Cost  
Education$1,931 $2,398 $4,467 $4,681 
Television broadcasting856 956 1,782 1,791 
Manufacturing224 246 552 641 
Healthcare93 108 279 280 
Automotive5  11  
Other businesses477 487 997 856 
Corporate office1,407 1,682 2,936 3,230 
  $4,993 $5,877 $11,024 $11,479 
Asset information for the Company’s business segments is as follows:
  As of
(in thousands)June 30, 2022December 31, 2021
Identifiable Assets    
Education$1,824,482 $2,026,782 
Television broadcasting429,070 448,627 
Manufacturing500,918 486,304 
Healthcare217,190 194,823 
Automotive268,156 238,200 
Other businesses623,159 689,872 
Corporate office112,979 68,962 
  $3,975,954 $4,153,570 
Investments in Marketable Equity Securities648,604 809,997 
Investments in Affiliates172,612 155,444 
Prepaid Pension Cost2,364,135 2,306,514 
Total Assets$7,161,305 $7,425,525 
24


The Company’s education division comprises the following operating segments:
  Three Months EndedSix months ended
  June 30June 30
(in thousands)2022202120222021
Operating Revenues      
Kaplan international$200,871 $181,276 $405,384 $353,171 
Higher education72,975 78,740 148,783 154,426 
Supplemental education77,546 77,911 153,850 157,566 
Kaplan corporate and other4,454 3,615 8,799 6,978 
Intersegment elimination(2,833)(1,558)(5,791)(2,840)
  $353,013 $339,984 $711,025 $669,301 
Income (Loss) From Operations before Amortization of Intangible Assets and Impairment of Long-Lived Assets
Kaplan international$19,063 $14,077 $39,627 $24,284 
Higher education2,704 2,374 7,741 8,627 
Supplemental education4,829 8,813 8,200 21,310 
Kaplan corporate and other(3,771)(6,042)(8,204)(10,949)
Intersegment elimination(56)(1)(37)97 
$22,769 $19,221 $47,327 $43,369 
Amortization of Intangible Assets$4,064 $3,914 $8,210 $8,079 
Impairment of Long-Lived Assets$ $2,159 $ $3,206 
Income (Loss) from Operations      
Kaplan international$19,063 $14,077 $39,627 $24,284 
Higher education2,704 2,374 7,741 8,627 
Supplemental education4,829 8,813 8,200 21,310 
Kaplan corporate and other(7,835)(12,115)(16,414)(22,234)
Intersegment elimination(56)(1)(37)97 
  $18,705 $13,148 $39,117 $32,084 
Depreciation of Property, Plant and Equipment
        
Kaplan international$5,794 $4,835 $11,549 $10,087 
Higher education1,064 873 2,084 1,725 
Supplemental education1,578 1,670 3,217 3,246 
Kaplan corporate and other95 104 186 204 
  $8,531 $7,482 $17,036 $15,262 
Pension Service Cost        
Kaplan international$63 $77 $135 $148 
Higher education820 1,137 1,901 2,220 
Supplemental education895 976 2,077 1,907 
Kaplan corporate and other153 208 354 406 
  $1,931 $2,398 $4,467 $4,681 
Asset information for the Company’s education division is as follows:
  As of
(in thousands)June 30, 2022December 31, 2021
Identifiable Assets    
Kaplan international$1,320,183 $1,493,868 
Higher education177,954 187,789 
Supplemental education268,054 286,877 
Kaplan corporate and other58,291 58,248 
  $1,824,482 $2,026,782 

25


Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition.
This analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto.
Results of Operations
The Company reported a net loss attributable to common shares of $67.5 million ($13.95 per share) for the second quarter of 2022, compared to income of $115.4 million ($22.99 per share) for the second quarter of 2021.
Items included in the Company’s net loss for the second quarter of 2022:
a $3.2 million net credit related to a fair value change in contingent consideration from a prior acquisition at Corporate (after-tax impact of $3.2 million, or $0.66 per share);
$165.5 million in net losses on marketable equity securities (after-tax impact of $122.4 million, or $25.05 per share);
$0.4 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $0.3 million, or $0.07 per share); and
$8.0 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $7.6 million, or $1.56 per share).
Items included in the Company’s net income for the second quarter of 2021:
a $2.6 million net credit related to a fair value change in contingent consideration from a prior acquisition at Corporate ($0.52 per share);
$3.4 million in long-lived asset impairment charges (after-tax impact of $2.6 million, or $0.51 per share);
$1.1 million in expenses related to a non-operating Separation Incentive Program (SIP) at manufacturing (after-tax impact of $0.8 million, or $0.16 per share);
$83.7 million in net gains on marketable equity securities (after-tax impact of $60.9 million, or $12.18 per share);
$1.4 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $1.0 million, or $0.21 per share);
a net non-operating gain of $14.5 million from the sale and write-up of cost method investments (after-tax impact of $10.7 million, or $2.13 per share); and
$1.0 million in interest income to adjust the fair value of the mandatorily redeemable noncontrolling interest ($0.19 per share).
Revenue for the second quarter of 2022 was $933.3 million, up 16% from $801.2 million in the second quarter of 2021. Revenues increased at education, television broadcasting, healthcare, automotive and other businesses, partially offset by a decline at manufacturing. The Company reported operating income of $39.3 million for the second quarter of 2022, compared to $37.6 million for the second quarter of 2021. Operating results increased at education, television broadcasting and automotive, offset by declines at manufacturing, healthcare and other businesses.
For the first six months of 2022, the Company reported net income attributable to common shares of $28.1 million ($5.74 per share), compared to $227.8 million ($45.43 per share) for the first six months of 2021.
Items included in the Company’s net income for the first six months of 2022:
a $3.2 million net credit related to a fair value change in contingent consideration from a prior acquisition at Corporate (after-tax impact of $3.1 million, or $0.64 per share);
$118.6 million in net losses on marketable equity securities (after-tax impact of $87.7 million, or $17.90 per share);
$0.1 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $0.1 million, or $0.01 per share);
Non-operating gain of $1.7 million from sales of an equity method and cost method investment (after-tax impact of $1.3 million, or $0.26 per share); and
$11.4 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $10.9 million, or $2.23 per share).
26


Items included in the Company’s net income for the first six months of 2021:
a $2.2 million net credit related to a fair value change in contingent consideration from a prior acquisition at Corporate ($0.44 per share);
$3.4 million in long-lived asset impairment charges (after-tax impact of $2.6 million, or $0.51 per share);
$1.1 million in expenses related to a non-operating SIP at manufacturing (after-tax impact of $0.8 million, or $0.16 per share);
$162.9 million in net gains on marketable equity securities (after-tax impact of $118.5 million, or $23.64 per share);
$8.9 million in net earnings of affiliates whose operations are not managed by the Company (after-tax impact of $6.5 million, or $1.29 per share);
a net non-operating gain of $17.2 million from the sale and write-up of cost method investments (after-tax impact of $12.7 million, or $2.54 per share); and
$0.1 million in net interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest ($0.02 per share).
Revenue for the first six months of 2022 was $1,848.0 million, up 22% from $1,513.6 million in the first six months of 2021. Revenues increased at education, television broadcasting, healthcare, automotive and other businesses, partially offset by a decline at manufacturing. The Company reported operating income of $79.3 million for the first six months of 2022, compared to $71.4 million for the first six months of 2021. Operating results increased at education, television broadcasting and automotive, offset by declines at manufacturing, healthcare and other businesses.
The COVID-19 pandemic and measures taken to prevent its spread significantly impacted the Company’s results for 2021 and, to a lesser extent, the first six months of 2022, largely from reduced demand for the Company’s products and services. The Company cannot predict the severity or duration of the pandemic, the extent to which demand for the Company’s products and services will be adversely affected or the degree to which financial and operating results will be negatively impacted.
Division Results
Education  
Education division revenue totaled $353.0 million for the second quarter of 2022, up 4% from $340.0 million for the same period of 2021. Kaplan reported operating income of $18.7 million for the second quarter of 2022, compared to $13.1 million for the second quarter of 2021.
For the first six months of 2022, education division revenue totaled $711.0 million, up 6% from $669.3 million for the same period of 2021. Kaplan reported operating income of $39.1 million for the first six months of 2022, compared to $32.1 million for the first six months of 2021.
The COVID-19 pandemic adversely impacted Kaplan’s operating results during 2021 and, to a lesser extent, the first six months of 2022. Kaplan serves a large number of students who travel to other countries to study a second language, prepare for licensure, or pursue a higher education degree. Government-imposed travel restrictions and school closures arising from COVID-19 had a negative impact on the ability of certain international students to travel and attend Kaplan’s programs, particularly at Kaplan International’s Language programs (Languages) in 2021.
In addition, Kaplan recorded $2.2 million and $3.2 million in impairment of long-lived asset charges in the second quarter and first six months of 2021, respectively.
27


A summary of Kaplan’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20222021% Change20222021% Change
Revenue            
Kaplan international$200,871 $181,276 11 $405,384 $353,171 15 
Higher education72,975 78,740 (7)148,783 154,426 (4)
Supplemental education77,546 77,911 153,850 157,566 (2)
Kaplan corporate and other4,454 3,615 23 8,799 6,978 26 
Intersegment elimination(2,833)(1,558)— (5,791)(2,840)— 
  $353,013 $339,984 $711,025 $669,301 
Operating Income (Loss)            
Kaplan international$19,063 $14,077 35 $39,627 $24,284 63 
Higher education2,704 2,374 14 7,741 8,627 (10)
Supplemental education4,829 8,813 (45)8,200 21,310 (62)
Kaplan corporate and other(3,771)(6,042)38 (8,204)(10,949)25 
Amortization of intangible assets(4,064)(3,914)(4)(8,210)(8,079)(2)
Impairment of long-lived assets
 (2,159)—  (3,206)— 
Intersegment elimination(56)(1)— (37)97 — 
  $18,705 $13,148 42 $39,117 $32,084 22 
Kaplan International includes postsecondary education, professional training and language training businesses largely outside the United States. Kaplan International revenue increased 11% and 15% for the second quarter and first six months of 2022, respectively (20% and 21%, respectively, on a constant currency basis). The increase is due largely to growth at Languages, Pathways and UK Professional. Kaplan International reported operating income of $19.1 million in the second quarter of 2022, compared to $14.1 million in the second quarter of 2021. Operating income increased to $39.6 million in the first six months of 2022, compared to $24.3 million in the first six months of 2021. The increase is due largely to a reduction in losses at Languages, and improved results at Pathways, partially offset by declines in Australia and Singapore and the adverse impact of foreign currency exchange rates. Overall, Kaplan International’s operating results were negatively impacted by $3 million and $9 million in losses, respectively, incurred at Languages from COVID-19 disruptions for the second quarter and first six months of 2022; compared to $12 million and $26 million in losses, respectively, incurred at Languages from COVID-19 disruptions for the second quarter and first six months of 2021. At the end of the second quarter of 2022, travel restrictions imposed as a result of COVID-19 have been substantially lifted, except in parts of Asia. Consequently, the Company expects significantly improved results at Languages and Australia for the remainder of 2022, assuming no new travel restrictions are imposed.
Higher Education includes the results of Kaplan as a service provider to higher education institutions. In the second quarter and first six months of 2022, Higher Education revenue declined 7% and 4%, respectively, due largely to lower costs incurred for reimbursement under the Purdue Global agreement. For the second quarter and first half of 2022 and 2021, Kaplan recorded a portion of the fee with Purdue Global based on an assessment of its collectability under the TOSA. Enrollments at Purdue Global for the first half of 2022 were approximately the same as the first half of 2021. The Company will continue to assess the collectability of the fee with Purdue Global on a quarterly basis to make a determination as to whether to record all or part of the fee in the future and whether to make adjustments to fee amounts recognized in earlier periods. Higher Education results increased in the second quarter of 2022 due to an increase in the Purdue Global fee recorded, partially offset by increased investment costs incurred related to other university agreements. Higher Education results declined in the first half of 2022 due to increased investment costs incurred related to other university agreements, partially offset by an increase in the Purdue Global fee recorded.
As of June 30, 2022, Kaplan had a total outstanding accounts receivable balance of $90.0 million from Purdue Global related to amounts due for reimbursements for services, fees earned and a deferred fee. Included in this total, Kaplan has a $19.3 million long-term receivable balance due from Purdue Global at June 30, 2022, related to the advance of $20 million during the initial KU Transaction.
Supplemental Education includes Kaplan’s standardized test preparation programs and domestic professional and other continuing education businesses. In November 2021, Supplemental Education acquired two small businesses. Supplemental Education revenue was flat compared to the second quarter of 2021 and declined 2% for the first six months of 2022 due largely to declines in retail comprehensive test preparation demand. Overall, demand for graduate and pre-college test preparation programs has declined due to the strength of U.S. employment markets and the decline in test-takers. Operating results declined in the second quarter and first six months of 2022 due to lower revenues and increased advertising and product development costs.
28


Kaplan corporate and other represents unallocated expenses of Kaplan, Inc.’s corporate office, other minor businesses and certain shared activities.
Television Broadcasting
A summary of television broadcasting’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20222021% Change20222021% Change
Revenue$122,386 $119,966 $245,805 $233,591 
Operating Income39,682 35,603 11 79,580 68,581 16 
Graham Media Group, Inc. owns seven television stations located in Houston, TX; Detroit, MI; Orlando, FL; San Antonio, TX; Jacksonville, FL; and Roanoke, VA, as well as SocialNewsDesk, a provider of social media management tools designed to connect newsrooms with their users. Revenue at the television broadcasting division increased 2% to $122.4 million in the second quarter of 2022, from $120.0 million in the same period of 2021. The revenue increase is due to a $2.6 million increase in political advertising revenue and a $1.1 million increase in retransmission revenues. Operating income for the second quarter of 2022 increased 11% to $39.7 million, from $35.6 million in the same period of 2021, due to increased revenues and a reduction in incentive compensation costs.
Revenue at the television broadcasting division increased 5% to $245.8 million in the first six months of 2022, from $233.6 million in the same period of 2021. The revenue increase is due to a $5.0 million increase in political revenue, a $3.6 million increase in retransmission revenues, and increases from winter Olympics and Super Bowl advertising revenue at the Company’s NBC affiliates in the first quarter of 2022. Operating income for the first six months of 2022 increased 16% to $79.6 million, from $68.6 million in the same period of 2021, due to increased revenues.
In May 2022, the Company’s television station in Orlando (WKMG) entered into a new network affiliation agreement with CBS that covers the period July 1, 2022 through June 30, 2026.
Manufacturing
A summary of manufacturing’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20222021% Change20222021% Change
Revenue$127,062 $141,123 (10)$243,002 $257,083 (5)
Operating Income4,502 12,428 (64)14,477 21,335 (32)
Manufacturing includes four businesses: Hoover, a supplier of pressure impregnated kiln-dried lumber and plywood products for fire retardant and preservative applications; Dekko, a manufacturer of electrical workspace solutions, architectural lighting and electrical components and assemblies; Joyce/Dayton, a manufacturer of screw jacks and other linear motion systems; and Forney, a global supplier of products and systems that control and monitor combustion processes in electric utility and industrial applications.
Manufacturing revenues declined 10% and 5% in the second quarter and first six months of 2022, respectively, due largely to a significant reduction in revenues at Hoover from lower wood prices and modestly lower product demand, offset by increased revenues at Dekko, Joyce, and Forney. Wood prices were highly volatile in 2021 and the first half of 2022. Overall, Hoover results included wood gains on inventory sales for both the first half of 2022 and 2021; however, wood gains on inventory sales were significantly higher in the first half of 2021. For the second quarter of 2022, Hoover results included wood losses on inventory sales, compared with significant wood gains on inventory sales in the second quarter of 2021. Manufacturing operating results declined 64% and 32% in the second quarter and first six months of 2022, respectively, due largely to declines at Hoover related to wood gains and losses on inventory sales during the relevant periods. Excluding the impact of wood gains and losses, Hoover results improved in the second quarter of 2022 and were down slightly in the first half of 2022. The declines at Hoover in the second quarter and first half of 2022 were partially offset by improved results at Dekko and Forney and reduced amortization of intangible assets expense.
In the second quarter of 2021, Dekko announced a plan to relocate its manufacturing operations in Shelton, CT to other Dekko manufacturing facilities, which was substantially completed by the end of 2021. In connection with this activity, Dekko implemented a SIP for the affected employees, resulting in $1.1 million in non-operating SIP expense recorded in the second quarter of 2021, which was funded by the assets of the Company’s pension plan.
29


Healthcare
A summary of healthcare’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20222021% Change20222021% Change
Revenue$76,385 $54,696 40 $143,640 $104,739 37 
Operating Income6,262 8,595 (27)12,621 15,735 (20)
Graham Healthcare Group (GHG) provides home health and hospice services in six states. In December 2021, GHG acquired two small businesses, one of which expanded GHG’s home health operations into Florida. In May 2022, GHG acquired two small businesses, one of which expanded GHG’s home health operations into Kansas and Missouri. GHG provides other healthcare services, including nursing care and prescription services for patients receiving in-home infusion treatments through its 75% interest in CSI Pharmacy Holdings Company, LLC (CSI). Healthcare revenues increased 40% and 37% for the second quarter and first six months of 2022, respectively, largely due to growth at CSI and home health services and from businesses acquired in the fourth quarter of 2021 and second quarter of 2022. The decline in GHG operating results in the second quarter and first six months of 2022 is due to increased marketing, human resources, recruiting and business development costs and overall increased compensation and transportation costs in nursing and clinical staffing, partially offset by improved results at CSI.
The Company also holds interests in four home health and hospice joint ventures managed by GHG, whose results are included in equity in earnings of affiliates in the Company’s Consolidated Statements of Operations. The Company recorded equity in earnings of $1.7 million and $2.7 million for the second quarter of 2022 and 2021, respectively, from these joint ventures. The Company recorded equity in earnings of $3.6 million and $5.5 million for the first six months of 2022 and 2021, respectively. During the first quarter of 2022, GHG, through its Residential Home Illinois and Residential Hospice Illinois affiliates, acquired an interest in the home health and hospice assets of NorthShore University HealthSystem, an integrated healthcare delivery system serving patients throughout the Chicago, IL area. The transaction resulted in a decrease to GHG’s interest in Residential Hospice Illinois and a $0.6 million non-operating gain was recorded in the first quarter of 2022 related to the change in interest.
Automotive
A summary of automotive’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20222021% Change20222021% Change
Revenue$147,602 $90,273 64 $298,569 $158,000 89 
Operating Income7,365 3,785 95 14,443 4,309 — 
Automotive includes four automotive dealerships in the Washington, D.C. metropolitan area: Ourisman Lexus of Rockville, Ourisman Honda of Tysons Corner, Ourisman Jeep Bethesda and Ourisman Ford of Manassas, which was acquired on December 28, 2021, from the Battlefield Automotive Group. Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, and his team of industry professionals operate and manage the dealerships; the Company holds a 90% stake.
Revenues for the second quarter and first six months of 2022 increased significantly due to the Ford dealership acquisition, sales growth at the Jeep dealership due to an increase in new vehicle inventory provided by the manufacturer, and higher average new and used car selling prices at the Jeep, Lexus and Honda dealerships as a result of strong customer demand and new vehicle inventory shortages related to supply chain disruptions and production delays at vehicle manufacturers, partially offset by volume declines at Honda and Lexus. Operating results for the second quarter of 2022 improved significantly due largely to the Ford acquisition and improved results at the Jeep dealership due to increased sales and margins, offset by declines at the Honda dealership due to inventory shortages. Operating results for the first six months of 2022 improved significantly due to the Ford acquisition and improved results at the Jeep, Lexus and Honda dealerships.
On July 5, 2022, the Company acquired a Toyota dealership and a Chrysler-Dodge-Jeep-Ram dealership in Woodbridge, VA from the Lustine Automotive Group.
30


Other Businesses
Leaf Group
On June 14, 2021, the Company acquired Leaf Group Ltd. (Leaf), a consumer internet company, headquartered in Santa Monica, CA, that builds enduring, creator-driven brands that reach passionate audiences in large and growing lifestyle categories, including fitness and wellness (Well+Good, Livestrong.com and MyPlate App), and home, art and design (Saatchi Art, Society6 and Hunker). Leaf has three major operating divisions: Society6 Group and Saatchi Art Group (Marketplace businesses) and the Media Group. Overall, Leaf reported significant operating losses for the second quarter and first six months of 2022.
Clyde’s Restaurant Group
Clyde’s Restaurant Group (CRG) owns and operates ten restaurants and entertainment venues in the Washington, D.C. metropolitan area, including Old Ebbitt Grill and The Hamilton. As a result of the COVID-19 pandemic, CRG temporarily closed its restaurant dining rooms in Maryland and the District of Columbia in December 2020, reopening again for limited indoor dining service in February 2021. Various government-ordered dining restrictions continued until the middle of 2021. CRG reported an operating profit for the second quarter and first six months of 2022; both revenues and operating results improved significantly from the second quarter and first six months of 2021 due largely to the absence of government-ordered dining restrictions in 2022 and a favorable rent concession that was recorded in the second quarter of 2022. Improvement in both revenue and operating results is expected to continue for the remainder of 2022.
Framebridge
Framebridge is a custom framing service company, headquartered in Washington, D.C., with sixteen retail locations in the Washington, D.C., New York City, Atlanta, GA, Philadelphia, PA, Boston, MA and Chicago, IL areas and two manufacturing facilities in Kentucky and New Jersey. Framebridge plans to open three additional stores in 2022. Framebridge revenues increased in the second quarter and first six months of 2022 due to operating additional retail stores compared to the same periods in 2021. Framebridge is an investment stage business and reported significant operating losses in the first six months of 2022 and 2021.
Code3
Code3 is a performance marketing agency focused on driving performance for brands through three core elements of digital success: media, creative and commerce. Code3 revenues increased modestly in the second quarter and first six months of 2022. Code3 reported operating losses in the second quarter and first six months of 2022 and 2021. In the second quarter of 2021, Code3 recorded a $1.6 million lease impairment charge (including $0.4 million in property, plant and equipment write-downs).
Other
Other businesses also include Slate and Foreign Policy, which publish online and print magazines and websites; and four investment stage businesses, CyberVista, Decile, Pinna and City Cast. Slate, Foreign Policy, Decile, Pinna and City Cast reported revenue increases in the first six months of 2022. Losses from each of these six businesses in the first six months of 2022 adversely affected operating results.
Overall, for the second quarter and first six months of 2022, operating revenues for other businesses increased due largely to the Leaf acquisition and increases at CRG and Framebridge. Operating results declined in the second quarter and first six months of 2022 due primarily to losses at Leaf and increased losses at Framebridge, partially offset by improved results at CRG.
Corporate Office
Corporate office includes the expenses of the Company’s corporate office and certain continuing obligations related to prior business dispositions. Corporate office expenses declined in the first six months of 2022 due primarily to lower incentive compensation costs.
Equity in Earnings (Losses) of Affiliates
At June 30, 2022, the Company held an approximate 12% interest in Intersection Holdings, LLC (Intersection), a company that provides digital marketing and advertising services and products for cities, transit systems, airports, and other public and private spaces. The Company also holds interests in several other affiliates, including a number of home health and hospice joint ventures managed by GHG and two joint ventures managed by Kaplan. Overall, the Company recorded equity in earnings of affiliates of $1.4 million for the second quarter of 2022, compared to $1.8 million for the second quarter of 2021. These amounts include $0.4 million and $1.4 million in net losses for the second quarter of 2022 and 2021, respectively, from affiliates whose operations are not managed by
31


the Company; this includes losses from the Company’s investment in Intersection in the second quarter of 2022 and 2021.
The Company recorded equity in earnings of affiliates of $4.0 million for the first six months of 2022, compared to $15.2 million for the first six months of 2021. These amounts include $0.1 million in net losses for the first six months of 2022 from affiliates whose operations are not managed by the Company compared to $8.9 million in net earnings for the first six months of 2021; this includes losses from the Company’s investment in Intersection in the first six months of 2022 and 2021.
Net Interest Expense and Related Balances
The Company incurred net interest expense of $15.3 million and $26.0 million for the second quarter and first six months of 2022, respectively; compared to $5.5 million and $13.0 million for the second quarter and first six months of 2021, respectively. The Company recorded interest expense of $8.0 million and $11.4 million in the second quarter and first six months of 2022, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG. The Company recorded interest income of $1.0 million in the second quarter of 2021 and net interest expense of $0.1 million in the first six months of 2021 to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG.
At June 30, 2022, the Company had $606.2 million in borrowings outstanding at an average interest rate of 4.8%, and cash, marketable equity securities and other investments of $808.7 million. At June 30, 2022, the Company had $150.8 million outstanding on its $300 million revolving credit facility. On May 3, 2022, the Company entered into an amended and restated revolving credit facility agreement, which among other things, extends the maturity date to May 30, 2027, and removes USD LIBOR as a benchmark interest rate for borrowings denominated in U.S. dollars.
Non-operating Pension and Postretirement Benefit Income, net
The Company recorded net non-operating pension and postretirement benefit income of $50.9 million and $101.4 million for the second quarter and first six months of 2022, respectively; compared to $25.2 million and $54.0 million for the second quarter and first six months of 2021, respectively.
In the second quarter of 2021, the Company recorded $1.1 million in expenses related to a non-operating SIP at manufacturing.
(Loss) Gain on Marketable Equity Securities, net
Overall, the Company recognized $165.5 million and $118.6 million in net losses on marketable equity securities in the second quarter and first six months of 2022, respectively; compared to $83.7 million and $162.9 million in net gains on marketable equity securities in the second quarter and first six months of 2021, respectively.
Other Non-Operating Income
The Company recorded total other non-operating income, net, of $1.2 million for the second quarter of 2022, compared to $16.1 million for the second quarter of 2021. The 2022 amounts included $0.8 million in gains related to the sale of businesses and contingent consideration, and other items; partially offset by $0.5 million in foreign currency losses. The 2021 amounts included $6.7 million in gains on the sale of cost method investments; $7.8 million in fair value increases on cost method investments; $0.7 million in foreign currency gains; $0.6 million in gains related to the sale of businesses and contingent consideration and other items.
The Company recorded total non-operating income, net of $4.1 million for the first six months of 2022, compared to $22.4 million for the first six months of 2021. The 2022 amounts included $1.7 million in gains related to the sale of businesses and contingent consideration; a $1.0 million gain on sale of a cost method investment; a $0.6 million gain on sale of an equity affiliate, and other items; partially offset by $1.5 million in foreign currency losses. The 2021 amounts included $6.8 million in gains on sales of cost method investments; $10.5 million in fair value increases on cost method investments; $1.4 million in gains related to the sale of businesses and contingent consideration; $0.7 million in foreign currency gains and other items.
Provision for Income Taxes
The Company’s effective tax rate for the first six months of 2022 and 2021 was 32.2% and 27.0%, respectively.
Earnings Per Share
The calculation of diluted earnings per share for the second quarter and first six months of 2022 was based on 4,842,383 and 4,870,316 weighted average shares outstanding, respectively, compared to 4,985,488 and 4,981,000, respectively, for the second quarter and first six months of 2021. At June 30, 2022, there were 4,850,326 shares outstanding. On September 10, 2020, the Board of Directors authorized the Company to acquire up to
32


500,000 shares of its Class B common stock; the Company has remaining authorization for 212,473 shares as of June 30, 2022.
Other
The Company continuously assesses relevant events and circumstances to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In the second quarter of 2022, the Company performed an interim impairment review at the Leaf marketplace and Framebridge reporting units due to significant operating losses at the reporting units, combined with a decline in general market conditions and in market multiples. The quantitative goodwill impairment analyses indicated the estimated fair values of these reporting units, included in other businesses, exceeded their carrying values as of June 30, 2022. The estimated fair values of these reporting units exceeded their carrying values by a margin less than 10%. The total goodwill at these reporting units was $79.0 million as of June 30, 2022, or 5% of the total goodwill of the Company.
In connection with the Company’s annual impairment testing in 2021, the Company performed a goodwill impairment review at all of its reporting units. At the time, the estimated fair value of the Dekko reporting unit at the manufacturing businesses exceeded its carrying values by a margin less than 25%. The total goodwill at this reporting unit was $47.8 million as of June 30, 2022, or 3% of the total goodwill of the Company. The estimated fair value of the Company’s other reporting units with significant goodwill balances exceeded their respective carrying values by a margin in excess of 25% at the time of the annual test.
It is possible that impairment charges, which may be material, could occur in the future, given changes in market conditions and the inherent variability in projecting future operating performance.
As previously communicated, the Company has been exploring opportunities to utilize surplus pension assets in a tax-efficient manner. This includes studying the viability of a transaction in which a part of the existing pension plan is spun off and then terminated in order to fund what is known as a Qualified Replacement Plan (QRP), which could allow the Company to utilize its pension surplus to fund and expand defined contribution benefits. Because of the complexities associated with these transactions and to ensure excise taxes of up to 50% would not be imposed, companies pursuing these transactions typically sought private letter rulings from the IRS prior to implementing them. However, in June 2022, the IRS announced that it will no longer issue private letter rulings on such transactions, and as a result, the Company is no longer actively considering this specific transaction.
Financial Condition: Capital Resources and Liquidity
The Company considers the following when assessing its liquidity and capital resources:
 As of
(In thousands)June 30, 2022December 31, 2021
Cash and cash equivalents$126,368 $145,886 
Restricted cash19,495 12,957 
Investments in marketable equity securities and other investments662,831 824,445 
Total debt606,152 667,501 
Cash generated by operations is the Company’s primary source of liquidity. The Company maintains investments in a portfolio of marketable equity securities, which is considered when assessing the Company’s sources of liquidity. An additional source of liquidity includes the undrawn portion of the Company’s $300 million revolving credit facility, amounting to $149.2 million at June 30, 2022.
In March 2020, the U.S. government enacted legislation, including the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) to provide stimulus in the form of financial aid to businesses affected by the COVID-19 pandemic. Under the CARES Act, employers may defer the payment of the employer share of FICA taxes due for the period beginning on March 27, 2020, and ending December 31, 2020. The Company deferred $21.5 million of FICA payments under this program, with $10.7 million of the deferred payments still payable at June 30, 2022. The remaining deferred balance is due by December 31, 2022.
The CARES Act also included provisions to support healthcare providers in the form of grants and changes to Medicare and Medicaid payments. In April 2020, GHG applied for and received $31.5 million under the expanded Medicare Accelerated and Advanced Payment Program, modified by the CARES Act. The Department of Health and Human Services (HHS) started to recoup this advance in April 2021 by withholding a portion of the amount reimbursed for claims submitted for services provided after the beginning of the recoupment period. During the six months ended June 30, 2022, an amount of $12.0 million was withheld by HHS and the Company expects the remaining balance of $0.5 million to be withheld from claims submitted in the next three months.
33


During the first six months of 2022, the Company’s cash and cash equivalents decreased by $19.5 million, due to the net repayment of borrowings, additional investments in marketable equity securities and equity affiliates, capital expenditures, dividend payments and share repurchases, which was offset by cash generated from operations and the proceeds from the sale of marketable equity securities. In the first six months of 2022, the Company’s borrowings decreased by $61.3 million, primarily due to repayments under the revolving credit facility.
At June 30, 2022, the Company held approximately $69 million in cash and cash equivalents in businesses domiciled outside the U.S., of which approximately $7 million is not available for immediate use in operations or for distribution. Additionally, Kaplan’s business operations outside the U.S. retain cash balances to support ongoing working capital requirements, capital expenditures, and regulatory requirements. As a result, the Company considers a significant portion of the cash and cash equivalents balance held outside the U.S. as not readily available for use in U.S. operations.
At June 30, 2022, the fair value of the Company’s investments in marketable equity securities was $648.6 million, which includes investments in the common stock of five publicly traded companies. During the first six months of 2022, the Company purchased $31.5 million of marketable equity securities and sold marketable equity securities that generated proceeds of $74.2 million. At June 30, 2022, the net unrealized gain related to the Company’s investments totaled $379.0 million.
The Company had working capital of $581.0 million and $680.8 million at June 30, 2022 and December 31, 2021, respectively. The Company maintains working capital levels consistent with its underlying business requirements and consistently generates cash from operations in excess of required interest or principal payments.
At June 30, 2022 and December 31, 2021, the Company had borrowings outstanding of $606.2 million and $667.5 million, respectively. The Company’s borrowings at June 30, 2022 were mostly from $400.0 million of 5.75% unsecured notes due June 1, 2026, $150.8 million in outstanding borrowings under the Company’s revolving credit facility and commercial notes of $45.6 million at the Automotive subsidiary. The Company’s borrowings at December 31, 2021 were mostly from $400.0 million of 5.75% unsecured notes due June 1, 2026, $209.6 million in outstanding borrowings under the Company’s revolving credit facility and commercial notes of $47.0 million at the Automotive subsidiary. The interest on the $400.0 million of 5.75% unsecured notes is payable semiannually on June 1 and December 1.
On May 3, 2022, the Company amended the revolving credit facility agreement to, among other things, extend the maturity date to May 30, 2027.
During the six months ended June 30, 2022 and 2021, the Company had average borrowings outstanding of approximately $648.8 million and $520.0 million, respectively, at average annual interest rates of approximately 4.5% and 5.0%, respectively. During the six months ended June 30, 2022 and 2021, the Company incurred net interest expense of $26.0 million and $13.0 million, respectively.
On July 5, 2022, the Company’s automotive subsidiary acquired two automotive dealerships, including the real property for the dealership operations. In addition to a cash payment and the assumption of $10.9 million in floor plan payables, the automotive subsidiary borrowed $77.4 million to finance the acquisition.
On April 12, 2022, Standard & Poor’s affirmed the Company’s credit rating and maintained the outlook as Stable.
The Company’s current credit ratings are as follows:
Moody’sStandard & Poor’s
Long-termBa1BB
OutlookStableStable
The Company expects to fund its estimated capital needs primarily through existing cash balances and internally generated funds, and, as needed, from borrowings under its revolving credit facility. As of June 30, 2022, the Company had $150.8 million outstanding under the $300 million revolving credit facility. In management’s opinion, the Company will have sufficient financial resources to meet its business requirements in the next 12 months, including working capital requirements, capital expenditures, interest payments, potential acquisitions and strategic investments, dividends and stock repurchases.
34


In summary, the Company’s cash flows for each period were as follows:
 Six Months Ended 
 June 30
(In thousands)20222021
Net cash provided by operating activities$99,408 $72,845 
Net cash used in investing activities(17,916)(310,508)
Net cash used in financing activities(89,571)(59,175)
Effect of currency exchange rate change(4,901)(684)
Net decrease in cash and cash equivalents and restricted cash$(12,980)$(297,522)
Operating Activities. Cash provided by operating activities is net income adjusted for certain non-cash items and changes in assets and liabilities. The Company’s net cash flow provided by operating activities were as follows:
 Six Months Ended 
 June 30
(In thousands)20222021
Net Income$29,951 $228,561 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation, amortization and long-lived asset impairments68,689 65,786 
Amortization of lease right-of-use asset33,473 36,774 
Net pension benefit
(90,971)(45,413)
Other non-cash activities130,623 (128,933)
Change in operating assets and liabilities(72,357)(83,930)
Net Cash Provided by Operating Activities$99,408 $72,845 
Net cash provided by operating activities consists primarily of cash receipts from customers, less disbursements for costs, benefits, income taxes, interest and other expenses.
For the first six months of 2022 compared to the first six months of 2021, the increase in net cash provided by operating activities is primarily driven by higher net income, net of non-cash adjustments, and changes in operating assets and liabilities. Changes in operating assets and liabilities were primarily the result of an increase in the collection of cash from customers that were offset by higher purchase of inventories and decreases in accounts payable and accrued liabilities.
Investing Activities. The Company’s net cash flow used in investing activities were as follows:
 Six Months Ended 
 June 30
(In thousands)20222021
Net proceeds from sales of (purchases of) marketable equity securities$42,765 $(10,407)
Purchases of property, plant and equipment(32,154)(27,502)
Investments in equity affiliates, cost method and other investments(27,950)(4,910)
Investments in certain businesses, net of cash acquired(3,053)(272,428)
Other2,476 4,739 
Net Cash Used in Investing Activities$(17,916)$(310,508)
Net proceeds from sale of (purchases of) marketable equity securities. During the first six months of 2022 and 2021, the Company sold marketable equity securities that generated proceeds of $74.2 million and $37.6 million, respectively. The Company purchased $31.5 million and $48.0 million of marketable equity securities during the first six months of 2022 and 2021, respectively.
Capital Expenditures. The amounts reflected in the Company’s Condensed Consolidated Statements of Cash Flows are based on cash payments made during the relevant periods, whereas the Company’s capital expenditures for the first six months of 2022 of $31.4 million include assets acquired during the quarter. The Company estimates that its capital expenditures will be in the range of $70 million to $80 million in 2022.
Investment in equity affiliates. During the first six months of 2022, GHG invested an additional $18.5 million in two affiliates to fund their acquisition of an interest in a health system in Illinois.
Acquisitions. In May 2022, GHG acquired two small businesses which are included in healthcare. During the first six months of 2021, the Company acquired all of the outstanding shares of Leaf for cash and the assumption of $9.2
35


million in liabilities related to their pre-acquisition stock compensation plan, which will be paid in the future. Leaf is included in other businesses.
On July 5, 2022, the Company’s automotive subsidiary acquired two automotive dealerships, including the real property for the dealership operations, which will be included in automotive.
Financing Activities. The Company’s net cash flow used in financing activities were as follows:
 Six Months Ended 
 June 30
(In thousands)20222021
Net payments under revolving credit facility$(47,000)$(2,304)
Repayments of borrowings(7,580)(2,071)
Net proceeds from (repayments of) vehicle floor plan payable14,121 (9,591)
Common shares repurchased(34,303)— 
Dividends paid(15,465)(15,106)
Other656 (30,103)
Net Cash Used in Financing Activities$(89,571)$(59,175)
Borrowings and Vehicle Floor Plan Payable. In the first six months of 2022, the Company made repayments on the $300 million revolving credit facility. In the first six months of 2022 and 2021, the Company used vehicle floor plan financing to fund the purchase of new, used and service loaner vehicles at its automotive division. The proceeds from (repayments of) the vehicle floor plan payable fluctuates with changes in the amount of vehicle inventory held by the automotive dealerships.
Common Stock Repurchases. During the first six months of 2022, the Company purchased a total of 57,709 shares of its Class B common stock at a cost of approximately $34.3 million. On September 10, 2020, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock. The Company did not announce a ceiling price or time limit for the purchases. At June 30, 2022, the Company had remaining authorization from the Board of Directors to purchase up to 212,473 shares of Class B common stock.
Dividends. The quarterly dividend rate per share was $1.58 and $1.51 for the first six months of 2022 and 2021, respectively. The Company expects to pay a dividend of $6.32 per share in 2022.
Other. During the first six months of 2022, the Company paid $4.7 million related to deferred payments from prior acquisitions. During the first six months of 2021, the Company paid $30.9 million related to contingent consideration and deferred payments from prior acquisitions, mostly for the 2020 acquisition of Framebridge. During the first six months of 2022 and 2021, the Company increased the borrowings under its cash overdraft facilities by $6.1 million and $4.4 million, respectively. In March 2021, Hoover’s minority shareholders put their remaining outstanding shares to the Company, which had a redemption value of $3.5 million.
There were no other significant changes to the Company’s contractual obligations or other commercial commitments from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Forward-Looking Statements
All public statements made by the Company and its representatives that are not statements of historical fact, including certain statements in this report, in the Company’s Annual Report on Form 10-K and in the Company’s 2021 Annual Report to Stockholders, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to the duration and severity of the COVID-19 pandemic and its effects on the Company’s operations, financial results, liquidity and cash flows. Other forward-looking statements include comments about expectations related to acquisitions or dispositions or related business activities, including the TOSA, the Company’s business strategies and objectives, anticipated results of license renewal applications, the prospects for growth in the Company’s various business operations and the Company’s future financial performance. As with any projection or forecast, forward-looking statements are subject to various risks and uncertainties, including the risks and uncertainties described in Item 1A of the Company’s Annual Report on Form 10-K, that could cause actual results or events to differ materially from those anticipated in such statements. Accordingly, undue reliance should not be placed on any forward-looking statement made by or on behalf of the Company. The Company assumes no obligation to update any forward-looking statement after the date on which such statement is made, even if new information subsequently becomes available.
36


Item 3. Quantitative and Qualitative Disclosures about Market Risk.
The Company is exposed to market risk in the normal course of its business due primarily to its ownership of marketable equity securities, which are subject to equity price risk; to its borrowing and cash-management activities, which are subject to interest rate risk; and to its foreign business operations, which are subject to foreign exchange rate risk. The Company’s market risk disclosures set forth in its 2021 Annual Report filed on Form 10-K have not otherwise changed significantly.
Item 4. Controls and Procedures.
(a) Evaluation of Disclosure Controls and Procedures
An evaluation was performed by the Company’s management, with the participation of the Company’s Chief Executive Officer (principal executive officer) and the Company’s Chief Financial Officer (principal financial officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of June 30, 2022. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures, as designed and implemented, are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.
(b) Changes in Internal Control Over Financial Reporting
There has been no change in the Company’s internal control over financial reporting during the quarter ended June 30, 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
37


PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
During the quarter ended June 30, 2022, the Company purchased shares of its Class B Common Stock as set forth in the following table:
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plan*Maximum Number of Shares that May Yet Be Purchased Under the Plan*
April11,762 $610.19 11,762 242,457 
May15,801 600.01 15,801 226,656 
June14,183 572.38 14,183 212,473 
41,746 $593.49 41,746 
*On September 10, 2020, the Company’s Board of Directors authorized the Company to purchase, on the open market or otherwise, up to 500,000 shares of its Class B Common Stock. There is no expiration date for this authorization. All purchases made during the quarter ended June 30, 2022 were open market transactions and some of these shares were purchased under a 10b5-1 plan.
38


Item 6. Exhibits.
Exhibit Number 
Description 
3.1
 
 
3.2
 
 
3.3
 
 
4.1
 
 
4.2
4.3
10.1
31.1
31.2
 
 
32
 
101.INS
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101
*     Furnished herewith.
39


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  GRAHAM HOLDINGS COMPANY
  (Registrant)
   
Date: August 3, 2022 /s/ Timothy J. O’Shaughnessy
  
Timothy J. O’Shaughnessy,
President & Chief Executive Officer
(Principal Executive Officer)
   
Date: August 3, 2022 /s/ Wallace R. Cooney
  Wallace R. Cooney,
Chief Financial Officer
(Principal Financial Officer)
40
Document

Exhibit 31.1
RULE 13a-14(a)/15d-14(a) CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Timothy J. O’Shaughnessy, Chief Executive Officer (principal executive officer) of Graham Holdings Company (the “Registrant”), certify that:
1.I have reviewed this quarterly report on Form 10-Q of the Registrant;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
 

/s/ Timothy J. O’Shaughnessy
Timothy J. O’Shaughnessy
Chief Executive Officer
August 3, 2022


Document

Exhibit 31.2
RULE 13a-14(a)/15d-14(a) CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Wallace R. Cooney, Chief Financial Officer (principal financial officer) of Graham Holdings Company (the “Registrant”), certify that:
1.I have reviewed this quarterly report on Form 10-Q of the Registrant;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
 
/s/ Wallace R. Cooney
Wallace R. Cooney
Chief Financial Officer
August 3, 2022


Document

Exhibit 32
SECTION 1350 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND THE CHIEF FINANCIAL
OFFICER
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Graham Holdings Company (the “Company”) on Form 10-Q for the period ended June 30, 2022 (the “Report”), Timothy J. O’Shaughnessy, Chief Executive Officer (principal executive officer) of the Company and Wallace R. Cooney, Chief Financial Officer (principal financial officer) of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Timothy J. O’Shaughnessy
Timothy J. O’Shaughnessy
Chief Executive Officer
August 3, 2022
 
/s/ Wallace R. Cooney
Wallace R. Cooney
Chief Financial Officer
August 3, 2022